Back to GetFilings.com



================================================================================

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-K


[X] Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934 for the fiscal year ended May 31, 2003

[_] Transition report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 for the transition period from _________ to _________


Commission File Number 1-10751



STAR MULTI CARE SERVICES, INC.
- --------------------------------------------------------------------------------
(Name of Registrant in its charter)



New York 11-1975534
- --------------------------------------------------------------------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)


33 Walt Whitman Road, Huntington Station, NY 11746
- --------------------------------------------------------------------------------
(Address of principal executive office) (Zip Code)


Issuer's telephone number, including area code: (631) 423-6689
------------------

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of Each Class Name of each exchange on which registered

Common Stock, par value $.001 per share NASD OTC Bulletin Board
- --------------------------------------- -----------------------


Securities registered pursuant to Section 12(g) of the Exchange Act: None

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Securities Exchange Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirement for the past 90 days.
Yes [X] No [_]

Check if there is no disclosure of delinquent filers in response to Item 405 of
Regulation S-K contained in this form, and no disclosure will be contained, to
the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [X]

On September 12, 2003 the aggregate market value of the Common Stock of Star
Multi Care Services, Inc. held by non-affiliates equaled 791,792 shares with a
market value of $63,634 (based upon the closing price of the Common Stock on
such date on the NASD OTC Bulletin Board).

As of September 12, 2003, the Registrant had 16,208,676 shares of Common Stock
outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

None
================================================================================

PART I

ITEM 1. DESCRIPTION OF BUSINESS

GENERAL BACKGROUND AND HISTORY

Star Multi Care Services, Inc. (the "Company") is in the business of providing
professional and paraprofessional home health care personnel services to
elderly, ill and physically challenged individuals in their homes, and to a
lesser extent the Company provides health care facility staffing services for
hospitals and skilled nursing facilities. As of the close of the Company's
fiscal year the Company was licensed and / or certified in five states to
provide a full array of health care personnel services, which included
Registered Nurses, Licensed Practical Nurses, Home Health Aide, Nurse Aide, and
Personal Care Aide services. In some states the Company was also licensed and /
or certified to provide Physical Therapy, Speech Therapy, Occupational Therapy,
Respiratory Therapy, and Medical Social Work services.

The Company was established in 1938 in Brooklyn, New York and was purchased by
present management in 1986 at which time the primary focus of the organization
was the provision of facility staffing and private duty nursing services. After
the Company was acquired management successfully secured, in 1989, New York
State Department of Health approval as a Licensed Home Care Services Agency.
This expanded the Company's scope of services into the home care market.
Management initiated an IPO in 1991 with the Company becoming publicly traded on
the NASDAQ SmallCap Market, and in 1995 the Company began trading on the NASDAQ
National Market. On November 11, 1999 the Company reverted to trading on the
NASDAQ SmallCap Market, and on July 10, 2002, it began trading on the NASD OTC
Bulletin Board. In addition, the Company has maintained accreditation by the
Joint Commission on Accreditation of Health Care Organizations (JCAHO) since
1992 and was most recently awarded in May 2002 Joint Commission Accreditation
with Commendations, attesting to the Company's commitment to the delivery of
high quality health care services.

In conjunction with the Premier Asset Purchase Agreement, the New York and New
Jersey locations / operations of the Company were fully transferred to Premier.
At fiscal year end, the Company maintained 5 licensed offices within the three
remaining states it operates in, which include Pennsylvania (3 offices), Ohio (1
office), and Florida (1 office). In the Ohio and Pennsylvania locations, the
Company also maintains as a provision of State licensing and contracting
requirements Medicare Certified Home Health Agency operations in these states.
Star maintains full functionality for service provision across the Company 7
days a week, 24 hours a day. As of the fiscal year end, the Company employs over
450 full-time and part-time employees and services over 1,000 clients annually.
Additionally, the Company also has its corporate facilities and executive
offices in Huntington Station, New York.

Historically, the Company grew through a series of acquisitions that began in
1992 with the acquisition of certain assets from Unity Healthcare Holding
Company, Inc. and its subsidiaries (Unity). This expanded the Company's
operations within its existing New York and the adjacent New Jersey markets by
adding new contract rights for provision of home care services. In addition, the
Unity acquisition added new operations in the state of Florida, which included
both, Medicare certified (later discontinued in 1999) and licensed operations in
South Florida.

In 1993, the Company further expanded its home care operations in New York
through the acquisition of certain assets of DSI Health Care Services, Inc.
(DSI). This acquisition added new contract relationships within the New York
County of Nassau with facility based Certified Home Health Care Agencies, Long
Term Home Health Care Programs, and Hospices as well as expanded the Company's
existing Medicaid operations within the County.

In May of 1995, the Company acquired certain assets of Long Island Nursing
Registry, Inc. ("LINR"), which again augmented its existing operations in Nassau
County by both adding new contracts and expanding existing contract
relationships. The acquisition of LINR expanded Company operations into the new
markets of Suffolk and Onondaga (Syracuse Area) Counties (NY) for provision of
contract Medicaid Personal Care Services, Medicaid Skilled Nursing Services and
a variety contracts with facility based Certified Home Health Agencies, Long
Term Home Health Care Programs, and Hospice Programs; however, the Company
formally withdrew from the Syracuse market on May 1, 1999 by closing this office
in conjunction with its consolidation and restructuring initiatives.

In August 1996, the Company and AMSERV Health Care, Inc. consummated a merger
whereby the Company acquired control of Amserv, which resulted in Amserv
becoming a wholly owned subsidiary of the Company. This acquisition
significantly expanded the Company within the northern and central New Jersey
markets by adding new office locations in New Jersey. Amserv Health Care of New
Jersey, Inc. was a provider of Medicaid and Medicaid Waiver reimbursed
paraprofessional services, as well as contract services with Certified Home
Health Agencies and Hospice Programs. In addition, this acquisition also brought
the Company operations in Ohio operating under the name of Amserv Health Care of
Ohio, Inc., d/b/a Central Star Home Health Services. This subsidiary company
provides Medicaid and Medicaid Waiver paraprofessional services as well as
facility staffing services for professional nursing staff. The office is also
Medicare Certified but currently provides no Medicare reimbursed services.

On September 9, 1997 the Company consummated an Agreement and Plan of Merger
with Extended Family Care Corporation (EFCC). The Agreement between the Company
and EFCC provided for the merger of EFCC Acquisition Corp. (Merger Sub), a New
York Corporation and a wholly-owned subsidiary of the Company with EFCC, with
EFCC merging with and into the Merger Sub. At the time, the EFCC acquisition
added to the Company's existing New York and New Jersey operations as well as
expanded these operations by introducing new service contracts that were similar
to and compatible with existing paraprofessional contracts in these regions.
Additionally, the Company added new market operations in Allentown,
Pennsylvania. This particular office predominantly specializes in the provision
of skilled Pediatric Nursing services. This office is both Medicaid approved and
Medicare certified.

2

On May 8, 2000, the Company through a subsidiary corporation, EFCC Acquisition
Corp. d/b/a Extended Family Care, acquired certain assets of the Pennsylvania
offices of US Home Care. The acquisition expanded the Company's existing
operations in Pennsylvania by adding three new locations in Philadelphia,
Lancaster and Pittsburgh. The acquisition introduced the Company into three new
major markets in Pennsylvania and added approximately $5 million in revenue. The
Philadelphia office was subsequently closed in December 2000.


SALE OF EXISTING OPERATIONS

On July 3, 2001, the Company entered into Purchase Agreement with Premier Home
Healthcare Services, Inc. ("Premier") to acquire selected assets of the
Company's wholly owned subsidiary, Amserv Healthcare of New Jersey, Inc.,
operating the New Jersey operations of the Company and the New York operations
of the Company, with an aggregate purchase price of $5.5 million, $4.0 million
and $1.5 million for the New Jersey and New York operations, respectively. Sale
of the New Jersey Assets was completed on August 31, 2001 subject to a post
closing adjustment to the purchase price based upon certain revenue thresholds.
Additionally, on August 31, 2001, the Company entered into a Management
Agreement with Premier for management and operation of the Company's New York
operations pending New York State regulatory approval and the Company's
stockholder approval. Upon receipt of all necessary approvals, the sale of the
Company's New York operations will be completed. The purchase price of the New
York operations was also subject to adjustment based upon certain revenue
thresholds. In the interim period between the effective date of the Management
Agreement with Premier and the closing of the New York operations, the Company
borrowed $800,000 from Premier which was secured by the assets that Premier was
to purchase in the form of a non-recourse promissory note. Additionally, under
the terms of the Purchase Agreement with Premier, Star had retained the account
receivables of the New York and New Jersey operations, equal to approximately
$4.5 million. Subsequent to the execution of the Purchase Agreement with Premier
and the closing of the New Jersey Assets in August 2001, the Company determined
that shareholder approval was not required for consummation of the sale of the
New York operations of the Company. As the Company has received New York State
regulatory approval for the sale of the New York operations and to facilitate
the closing of the sale of the these assets without shareholder approval, the
Company agreed to a consensual foreclosure of the New York operations by
Premier, whereby all of the assets related to the Company's New York operations
were transferred to Premier. Upon the completion of this consensual foreclosure,
the New York operations were transferred to Premier, in the same manner had a
closing actually occurred, with no additional liability incurred by the Company.
This foreclosure was completed by the end of 2002.

The Company used the proceeds from the transaction with Premier to pay-off and
terminate its credit facility with Healthcare Finance Group, Inc. ("HFG"). The
Company paid HFG a total of $4.4 million in debt obligations and fees.

ORGANIZATIONAL RESTRUCTURING CHANGES

Although the Company had implemented organizational restructuring plans over the
1999 and 2000 fiscal years in response to industry related reimbursement and
regulatory changes, the Company again initiated additional restructuring
activities in fiscal year 2001. This was done in response to: (1) continued
service volume shrinkage across the industry in all areas of reimbursement
including Medicare, Medicaid and commercial insurance; (2) the Company's need to
improve profitability in order to reduce financial obligation liabilities, and
(3) the Company's inability to secure adequate numbers of personnel to expand
client service volume due to an industry wide personnel shortage. The
restructuring activities were initiated and completed in the Company's second
quarter. These restructuring activities included;

o Senior and middle management personnel changes.
o General staff consolidations and reductions.
o The closure of all non-profitable, marginally profitable and under
performing divisions and locations.
o The elimination of under performing, low margin and poor paying contracts.

In the 1999 and 2000 fiscal years, the Company also initiated and completed the
consolidation of certain licensed offices in both Florida and New York. The
licensed offices located in Miami Lakes and Lake Worth were consolidated and
centralized into the Company's Hollywood office to increase operational
efficiency in the region and reduce cost. Simultaneously, the Company terminated
certain under-performing low margin managed care contracts in the region to
increase the regional operating margin. Additionally, the Company, effective
February 26, 1999, discontinued Medicare Certified Home Health Agency operations
in Florida due to changes in the Medicare reimbursement and authorization
methodologies. In May 1999 the Company closed its Syracuse office due to cost
containment considerations.

Effective January 1, 1999, the Company successfully completed an 18 month,
automation restructuring project by placing all offices on the same operating
software for client intake, scheduling, personnel, clinical data base
management, billing and compliance. The system downloads data to the Resource
Center into a standard accounting package for payroll, billing, collection,
financial and general ledger processing. These changes marked a significant
transition from multiple operating systems to one integrated standardized
operating system. The Company continues to upgrade these systems to the most
recent releases available.

The Company continues to maintain a three-tier Corporate Compliance structure,
which includes:

1. Corporate Patient Care Committee which meets quarterly to review and
establish new policies and procedures, and reviews internal audit findings
by department and branch;
2. Regional Quality Improvement Audit Committees, which conduct a series of
operational, financial, clinical and personnel audits across all offices
and departments. These audits test all regulatory and operational aspects
with all findings reported to the Director of Corporate Compliance. The
Corporate Compliance Program provides an additional layer of internal
audits, investigation, and reporting. The program provides for a Director
of Corporate Compliance who operates under the direction of and reports
directly to the Company's Board of Directors.

3

CUSTOMER BASE

The Company maintains four types of customers, which form the base of its
referral source. The customer base includes Federally and State funded public
assistance programs (Medicaid), other third party payors (subcontracts),
insurance companies and private pay customers.

A substantial portion of the Company's revenue is derived from home health care
services provided to patients who are eligible for Medicaid and Aging related
services referred to the Company through contract or subcontract relationships.
The Company maintained State and / or County approval and / or contracts in New
York, New Jersey, Ohio, and Pennsylvania for provision of professional and
paraprofessional Medicaid services which include Registered Nurse, Licensed
Practical Nurse, Home Health Aide, Personal Care Aide, Homemaking, and Live-in
Companion services. Each State maintain(ed/s) its own initial approval and
annual re-approval criteria, which are subject to audit and / or accreditation
processes. These services are reimbursed directly by State and / or local
government and represent a combination of federal, state and local funding.
Clients are referred to the Company by physicians, hospital discharge planning
departments and community based medical service organizations. The majority of
the business in the states of New York, New Jersey, Ohio, and Pennsylvania
was/is Medicaid reimbursed. If a contract was to be lost or an annual approval /
accreditation not secured, it could have a material and adverse effect on the
Company's operating results.

Although the Company discontinued Medicare operations in the State of Florida,
it is still federally certified to provide Medicare reimbursed Certified Home
Health Agency services in the states of Ohio and Pennsylvania; however, the
Company conducts no Medicare reimbursed business in these states.

During the fiscal years ended May 31, 2003, 2002, and 2001, 65%, 70% and 63%,
respectively, of the Company's revenue was attributable to Medicaid programs.

The Company's next largest customer base is derived from other third party
payors which consist of subcontracting relationships for provision of personnel
with community and facility based organizations that are reimbursed directly by
Medicaid or other governmental services, and insurance companies. This source
has accounted for 33%, 28% and 40% of revenue for fiscal years 2003, 2002, and
2001, respectively.

Private pay customers have represented approximately 1% - 2% of revenue in each
of the last three fiscal years. These clients for a variety of reasons choose to
pay privately because the client is ineligible for public assistance programs,
chooses to supplement services provided by Medicare or an insurance program, or
have elected to pay part or all of their care out of pocket. These customers
come predominantly through referrals from physicians, hospital discharge
planners, and community based organizations.

MARKETING AND SALES

The Company maintained marketing and sales activities in each of the five states
it operated in and concentrated its efforts through the use of regional
marketing/sales teams comprised of field service office administration and sales
representatives. The office Administration educated the sales staff regarding
new identified targets, regulatory changes and new service programs. The Company
believes in the use of office specific Operational Plans for the management and
marketing of regional sales. Post Premier acquisition marketing activities are
conducted by the Office Administrator of each facility. The offices utilize a
formal Operational Plan. The individual Office Operational Plan format provides
for the comprehensive approach to office growth, marketing, and recruitment, as
well as the clinical and fiscal operation of each office. The plan objective is
to maximize internal growth and assure clinical / fiscal integrity. The plan
serves as the framework for development of a continual process for Quality and
Performance Improvement in all areas of responsibility including marketing. The
marketing component of the plan identifies all potential referral sources and
establishes a systematic referral source contact strategy across the marketing
and office staff. The plan is continually reassessed by management and refined
to ensure success, and serves as an evaluation tool to identify strengths as
well as areas needing organizational support.

The Company's office staff focuses on the sales and marketing component goals of
these plans. The Company targets the key representatives of the contracting
institutions, hospital discharge planning departments, insurance companies,
community based facilities, and physicians to secure contractual and referral
relationships. Representatives visit targeted facilities and programs, while
maintaining the Company's presence with existing referral sources and acting as
the first line of communication with new referral sources. Beyond the
traditional personnel services offered by the industry the Company offers
facility staffing, Shared Aide Team Model services, Skilled High Tech Nursing
and Pediatric Nursing specialty services. From an operational perspective the
Company markets quality benchmarks as demonstrated by its Joint Commission
accreditation (JCAHO), and a full functioning Corporate Compliance Program. The
sales representatives are supported by print and radio advertising, direct
mailing, and attendance at trade shows and regional health care functions.

COMPETITION

The home health care and facility staffing industry has a variety of local,
regional and national organizations, which comprise the Company's competition
base. The Company has numerous competitors in each of the markets it serves,
however, regulatory and reimbursement changes are causing consolidation within
the industry at this time. Smaller local and regional operations are finding it
increasingly difficult to remain in the market. Companies similar in size to
Star or larger regionally based companies have emerged to be viewed by the
Company as its major competitors.

Competition is based on the quality of care provided to clients, the ability to
obtain personnel to deliver the authorized service and the price structure
offered by the organization. The Company believes that it has developed and
maintains high quality standards through its operational, clinical, and
compliance policies, procedures and activities. Additionally, the Company
maintains an aggressive recruitment and training philosophy, which has proven
effective. Cost effectiveness in operation, achieved through improved automation
platforms, new service delivery models, and economies of scale have enabled the
Company to be aggressive in its pricing structures while maintaining strong
operating margins.

4

GOVERNMENT REGULATIONS, LICENSING AND AUDITS

The Company's business is subject to substantial and frequently changing
regulations by Federal, State, and Local authorities, which require significant
compliance responsibilities by the Company. Each State in which the Company
operates, maintains its own form of licensing standards and may maintain
Certificate of Need (CON) specific to the State that are above the minimum
standard requirements established by the Federal government for participation in
the Medicaid program. The imposition of more restrictive regulatory requirements
or the denial or revocation of any license, certification, Medicaid approval, or
permit necessary for operation in a particular market could have a material
adverse effect on the Company's operations. In addition, any future expansion
into new markets would require the Company to comply with all licensing, and /
or CON requirements and other regulations pertinent to that jurisdiction.

As of the close of fiscal year 2003, the Company continues to maintain all
applicable licenses and certifications in the states of Pennsylvania, Ohio, and
Florida. As a provider of services under some state Medicaid programs, the
Company is required by the Federal Health Care Financing Administration and / or
state Health Departments to prepare cost reports reflecting annual expenditures
and development of capital expenditure plans. The regulatory agencies of the
states in which the Company operates require compliance with certain regulations
and standards with respect to health care personnel records, client records,
nursing and administrative supervision, incident and complaint monitoring and
follow-up, and the establishment of professional advisory boards. Additionally,
both Federal and State Anti-kickback regulations exist which are complied with.

With participation in the Medicaid program, the Company is subject to survey and
audit of operational, clinical and financial records with respect to proper
applications of general regulations governing operation, cost reporting
criteria, and other payment formulas. These audits can result in retroactive
adjustments for payments received from these programs resulting in either
amounts due to governmental agencies from the Company or amounts due to the
Company as adjustments from the governmental agency.


LIABILITY INSURANCE

The Company's employees and subcontractors routinely make decisions that can
have significant medical consequences to the patients in their care. As a
result, the Company is exposed to substantial liability in the event of
negligence or wrongful acts of its personnel. The Company maintains medical
professional liability insurance providing for coverage in a maximum amount of
$1,000,000 per claim, subject to a limitation of $3,000,000 for all claims in
any single year. In addition, the Company requires that each independent
contractor it refers to institutions for employment supply a certificate of
insurance evidencing that such person maintains medical professional liability
insurance providing for coverage of no less than $1,000,000 per claim. There can
be no assurance, however, that the Company will be able to maintain its existing
insurance at an acceptable cost or obtain additional insurance in the future, as
required. There can be no assurance that the Company's insurance will be
sufficient to cover liabilities resulting from claims that may be brought in the
future. A partially or completely uninsured claim, if successfully asserted and
of significant magnitude, could have a material adverse effect on the Company
and its financial condition.


EMPLOYEES

At the end of fiscal 2003, the Company employed 53 permanent and part time
office and administrative employees. The Company also has a roster of temporary
professional and paraprofessional employees (including registered nurses,
licensed practical nurses, home health aides, personal care aides and nurses'
aides). The Company treats all such persons as employees. The Company currently
has no union contracts with any of its employees and believes that its
relationship with its employees and independent contractors is good. The Company
pays its temporary employees at wages that it believes are competitive within
industry standards.


RECRUITMENT OF PERSONNEL

Recruitment of adequate numbers of temporary personnel continues to be
increasingly difficult in the home health industry resulting from a variety of
market forces. The previously strong economic environment, coupled with a
moderate to low reimbursement rate structure has hampered the industry in
general in recruiting adequate numbers of personnel to provide authorized
services. Field service personnel wages and benefit packages are below average
as compared to other service type industries outside of health care. Although
the downward economy should result in an influx of personnel available to the
industry, this trend has yet to occur.

To address this issue, the Company has focused on higher margin business or
attempted to negotiate revised contractual rate agreements with existing
referral sources in an effort to permit the Company to offer increased wage and
benefit packages to its temporary employees.

Additionally, the Company's focus has been on filling all monthly
office-training programs, development of off-site recruitment initiatives and
training locations, and recruitment of professional nursing personnel. This
project was implemented in March 2000 and has been moderately successful,
although future success of the program cannot be guaranteed.


ITEM 2. DESCRIPTION OF PROPERTY

DESCRIPTION OF PROPERTY

The Company leased at the end of fiscal 2003, a total of 6 facilities in four
states. The Company believes that its existing leases will be negotiated as
appropriate as they expire, or that alternative properties can be leased on
acceptable terms. The Company relocated its Resource Center from Florida to its
Corporate headquarters in New York in an effort to reduce operational costs. The
Company also believes that its present facilities are well maintained and are
suitable for it to maintain existing operations.

5

The following table describes the location and current use of each of the
Company's leased facilities as of May 31, 2003:

LOCATION DESCRIPTION
- -------- -----------
New York Facilities Corporate Executive Offices,
Huntington Station Finance and Administration

Florida Facilities
Pembroke Pines Nursing and Paraprofessional Services

Ohio Facilities
Mansfield Nursing and Paraprofessional Services

Pennsylvania Facilities
Allentown, Lancaster, Pittsburgh Nursing and Paraprofessional Services



ITEM 3. LEGAL PROCEEDINGS

On July 16, 1998, the Company was advised that an audit of Star Multi Care
Services of Florida, Inc. (d/b/a American Health Care Services) ("American"),
the Company's Florida Medicare agency, was commenced by the Office of Audit
Services, Office of Inspector General of the United States Department of Health
and Human Services. This audit was conducted in conjunction with the United
States Attorney's Office for the Southern District of Florida and involved a
review of claims for home health services submitted by American Health Care
Services during 1995 and 1996. On July 11, 2001 the Company entered into a
Settlement Agreement with United States Department of Justice and the Office of
Inspector General of the Department of Health and Human Services. In order to
avoid the delay, uncertainty, inconvenience, and the expense of protracted
litigation of the claims, both parties mutually agreed upon a settlement amount
of $1.0 million payable by Star no later than November 8, 2001. The agreement
was subsequently amended to permit an extension of payment and, in April 2003,
the obligation was satisfied in full.

On May 10, 1999 the Company entered into a Settlement Agreement with the State
of New York, whereby the State of New York will discharge and forever release
the Company, including its officers, directors and employees, for any further
liability regarding the Company's submission of claims for or receipt of
Medicaid payments for home health care services for the audited period of 1992
through 1996. The Attorney General stated in his press release that the Company
has fully cooperated with the State's investigation and immediately remedied the
problems the Attorney General's office pointed out by improving its personnel
training procedures and submitting revised cost reports.

The terms of this Settlement Agreement provided for:

(a) No admission by Star of any criminal or civil liability, guilt, wrongdoing
or unacceptable practice, or a determination of guilt of any violation of
any Federal, State or Local statute, rule or regulation.

(b) The Company agreed to pay to New York State the total sum of $1,167,177,
with an initial payment of $200,000. The balance was payable over four
years at 9% interest.

This obligation was satisfied in full in May 2003.


Except as otherwise provided in this Annual Report on Form 10-K, there are no
legal proceedings to which the Company is currently a party, or to which any of
its property is subject, that could possibly have a material adverse effect upon
the Company. Further, the Company knows of no legal proceeding pending or
threatened against any director or officer of the Company in their capacity as
such.



PART II

ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

Prior to November 11, 1999, the Company's Common Stock was quoted on the Nasdaq
National Market System, under the symbol "SMCS", and from November 11, 1999
through July 10, 2002, has been traded on the Nasdaq SmallCap market, under the
symbol "SMCS", and thereafter has been traded on the NASD OTC Bulletin Board
under the symbol "SMCS". Until June 7, 1996, the Company's Common Stock was also
listed on the Pacific Stock Exchange.

The following table sets forth the high and low sales prices per share for the
Common Stock during the periods indicated on the Nasdaq National Market System
or the Nasdaq SmallCap Market.
6

PERIOD HIGH LOW
------ ------ ------
Year ended May 31, 2001 $ 6.75 $ 4.12
First Quarter 4.31 1.88
Second Quarter 2.34 1.62
Third Quarter 1.80 1.39
Fourth Quarter

Year ended May 31, 2002
First Quarter $ 2.42 $ 1.80
Second Quarter 1.70 0.56
Third Quarter 0.71 0.39
Fourth Quarter 0.85 0.41

Year ended May 31, 2003
First Quarter $ 0.20 $ 0.69
Second Quarter 0.14 0.03
Third Quarter 0.13 0.05
Fourth Quarter 0.13 0.05

As of September 12, 2003, the Company had 16,208,676 shares of Common Stock
outstanding and 734 shareholders of record.

The Company did not pay cash dividends on its Common Stock during any of the
past three fiscal years. It is the present policy of the Company to retain
earnings, if any, to finance the development and growth of its business. In
addition, the Company's agreement with its lender prohibits the payment of cash
dividends without the lender's prior consent.

On July 10, 2002, the Nasdaq Stock Market notified the Company that it did not
meet the maintenance criteria regarding the minimum market value of the public
float of at least $1 million, or a minimum shareholders' equity of $2.5 million,
for continued listing on the Nasdaq SmallCap Market. Accordingly, the Company's
stock has been delisted from Nasdaq, but is traded on the NASD OTC Bulletin
Board.

On July 24, 2002, the Company entered into a Securities Purchase and Exchange
Agreement with the holder of the Series A 8% Convertible Preferred Stock whereby
all of the outstanding and unconverted Series A 8% Convertible Preferred Stock,
including the accrued and unpaid dividends from the Series A Preferred Stock was
exchanged for 477 shares Series B 7% Convertible Preferred Stock, with each
share valued at $1,000, or a total of $477,000. The terms of the Series B 7%
Convertible Preferred Stock differs to the terms of the Series A 8% Convertible
Preferred Stock as follows: (i) the dividend on the preferred stock is 7% per
annum as compared to 8% on the Series A, (ii) the conversion price is equal to
the lesser of: (a) 125% of the market price three trading days immediately
preceding the closing date, or (b) the market price of the Company's common
stock discounted by 71% of the market rate, as compared to 70% for the Series A,
(iii) as the Company was not listed on The Nasdaq SmallCap Market at the time of
the issuance of the Series B stock, there is no limitation on the total
percentage of common stock that may be issues upon conversion as compared to the
number of outstanding common stock shares that existed at the time of issuance
of the Series B shares. The Series A shares had a 20% limitation to comply with
The Nasdaq Marketplace Rules.


ITEM 6. SELECTED FINANCIAL DATA

The statement of operations for the years ended May 31, 2003, 2002, 2001, 2000,
and 1999 and balance sheet data as of May 31, 2003, 2002, 2001, 2000, and 1999
as set forth below have been derived from the audited financial statements of
the Company and should be read in conjunction with those financial statements
and notes thereto included elsewhere in this Annual Report on Form 10-K. In
addition, the selected financial data should be read in conjunction with
"Description of Business -- General" and "Management's Discussion and Analysis
of Financial Condition and Results of Operations."

7


YEAR ENDED MAY 31
------------------------------------------------------------
2003 2002 2001 2000 1999
-------- -------- -------- -------- --------

(IN THOUSANDS EXCEPT RATIO AND PER SHARE AMOUNTS)
STATEMENT OF OPERATIONS DATA (4)

Net Revenue $ 10,475 $ 15,077 $ 38,679 $ 39,206 $ 47,108

Income (Loss) from Operations (118) (1,732) (7,985) 103 (1,316)

Other Income (Expense) (134) (364) (773) (731) (652)

Loss from Continuing Operations (1,328) (2,638) (8,759) (628) (1,322)

Extraordinary Item, net -- -- -- -- --

Loss from Discontinued Operations (4) -- -- (1,000) (36) (145)

Loss on Disposal of Discontinued Operations (6) -- -- -- -- (88)

Net Loss (1,328) (1,085) (9,759) (664) (1,556)


Income (Loss) Per Share (3)

Loss from Continuing Operations $ (.37) $ (3.21) $ (14.21) $ (1.17) $ (2.28)

Loss from Discontinued Operation $ -- $ -- $ (1.62) $ (0.06) $ (0.24)

Loss on Disposal of Discontinued Operations -- -- -- $ -- (0.15)

Extraordinary Item $ -- $ 1.85 $ 0 $ 0 $ 0

Net Loss $ (.37) $ (1.36) $ -- $ (1.23) $ (2.67)

Shares Used in Computing Per Share Amounts 3,767 842 619 579 582



BALANCE SHEET DATA:

Cash and Cash Equivalents $ 190 $ 74 $ 10 $ 321 $ 1,734

Working Capital 1,327 1,471 (6,023) 3,696 6,068

Total Assets 4,758 5,729 15,457 24,430 28,171

Total Long-Term Obligations 0 0 312 5,784 7,601

Redeemable Preferred Stock -- -- -- -- --

Shareholders' Equity 965 2,216 2,880 12,658 13,388

Current Ratio 0.65 0.58 0.51 1.62 1.85

Cash Dividend Declared Per Common Share $ -- $ -- $ -- $ -- $ --

______________________

(3) Effective January 1, 1998, STAR adopted SFAS No. 128, "Earnings Per Share."
(4) Effective February 1999, STAR adopted a plan to abandon its Medicare
business provided by one of its subsidiaries, Star Multi Care Services of
Florida, d/b/a American Health Care Services as such operations of American
have been shown as discontinued for all periods presented.


ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATION

The following discussion and analysis provides information, which the Company's
management believes is relevant to an assessment and understanding of the
Company's results of operations and financial condition. This discussion should
be read in conjunction with the consolidated financial statements and notes
thereto, appearing elsewhere herein. All references to years or year ends are to
the Company's fiscal periods, which end on May 31.

This discussion contains forward-looking statements that are subject to a number
of known and unknown risks that, in addition to general economic, competitive
and other business conditions, could cause actual results, performance and
achievements to differ materially from those described or implied in the
forward-looking statements [See Forward Looking Statements].

The Company is subject to significant external factors that could have a
significant impact on its business, including changes in Medicaid reimbursement,
government fraud and abuse initiatives, and other such factors that are beyond
the control of the Company. These factors, as well as future changes in
reimbursement methodologies and new or changes in interpretations of
regulations, could cause future results to differ materially from historical
trends.

CRITICAL ACCOUNTING POLICIES

The consolidated financial statements of the Company include accounts of the
Company and all majority-owned and controlled subsidiaries. The preparation of
financial statements in conformity with accounting principles generally accepted
in the United States ("GAAP") requires management to make estimates and
assumptions in certain circumstances that affect amounts reported in the
Company's consolidated financial statements and related notes. In preparing
these financial statements, management has utilized information available
including its past history, industry standards and the current economic
environment, among other factors, in forming its estimates and judgments of
certain amounts included in the consolidated financial statements, giving due
consideration to materiality. It is possible that the ultimate outcome as
anticipated by management in formulating its estimates inherent in these
financial statements might not materialize. However, application of the critical

8

accounting policies below involves the exercise of judgment and use of
assumptions as to future uncertainties and, as a result, actual results could
differ from these estimates. In addition, other companies may utilize different
estimates, which may impact comparability of the Company's results of operations
to those of companies in similar businesses.

Revenue Recognition

Net patient service revenue is reported at estimated net realizable amounts from
patients, third-party payors, and others for services rendered and includes
estimated retroactive revenue adjustments due to future audits, reviews, and
investigations. Retroactive adjustments are considered in the recognition of
revenue on an estimated basis in the period the related services are rendered,
and such amounts are adjusted in future periods as adjustments become known or
as years are no longer subject to such audits, reviews and investigations. A
provision for doubtful accounts is made for revenue estimated to be
uncollectible and is adjusted based upon management's evaluation of current
industry conditions, historical collection experience and other relevant factors
which, in the opinion of management, deserve recognition in estimating the
allowance for doubtful accounts.

Under Medicaid, Medicare and other cost-based reimbursement programs, the
Company is reimbursed for services rendered to covered program patients as
determined by reimbursement formulas. Laws and regulations governing the
Medicaid programs are extremely complex and subject to interpretation. As a
result, there is at least a reasonable possibility that recorded estimates will
change by a material amount in the near term.

Goodwill and Intangible Assets

Goodwill, which represents the excess of purchase price over the fair value of
net assets acquired, was being amortized on a straight-line basis over the
expected future periods to be benefited, ranging from five to forty years.
Effective June 1, 2002, we adopted SFAS No. 142, which eliminates amortization
of goodwill and intangible assets deemed to have indefinite lives, and requires
these assets to be subject to annual impairments tests. Intangible assets
consist of customer contracts acquired in connection with our business
acquisitions.

We completed the annual impairment test required by SFAS No. 142 during the
first quarter of fiscal 2003 by comparing the fair value of our reporting units
with their carrying values. We also reassessed the useful lives of other
intangibles that are amortized. As of June 1, 2002 we concluded that the fair
values of the reporting units exceeded the carrying values of the reporting
units. Therefore, no impairment charge was recognized in fiscal 2003 and no
changes were made to the useful lives of our intangibles. Considerable
management judgment is necessary to estimate the fair value of our reporting
units, which may be impacted by future actions taken by us and our competitors
and the economic environment in which we operate. These estimates affect the
balance of Goodwill and Intangible Assets on our Consolidated Balance Sheets and
Operating Expenses on our Consolidated Statements of Operations and
Comprehensive (Loss) Income.

Stock-Based Compensation

The Company applies the intrinsic value-based method of accounting prescribed by
Accounting Principles Board ("APB") Opinion No. 25, Accounting for Stock Issued
to Employees, and related interpretations, to account for stock-based employee
compensation plans and reports pro forma disclosures in its Form 10-K filings by
estimating the fair value of options issued and the related expense in
accordance with SFAS No. 123. Under this method, compensation cost is recognized
for awards of shares of common stock or stock options to directors, officers and
employees of the Company only if the quoted market price of the stock at the
grant date (or other measurement date, if later) is greater than the amount the
grantee must pay to acquire the stock.

RESULTS OF OPERATIONS

Year Ended May 31, 2003 Compared to Year Ended May 31, 2002

Net revenue for the year ended May 31, 2003 decreased $4,602,350 or 31% to
$10,474,784, compared to $15,077,134 for the year ended May 31, 2002. This
decrease was primarily attributable to the sale and closing of the Company's New
York and New Jersey facilities in August 2001, offset in part by the growth in
remaining office revenue for the comparable nine month periods following these
closings. Revenue for the nine months ended May 31, 2003 was $8,085,431, as
compared to revenue of $7,092,934 for the nine months ended May 31, 2002.

Gross profit margin percentages for the years ended May 31, 2003 and 2002 were
comparable at 35.6% and 35.4%, respectively. Increasing costs, primarily
workers' compensation, are placing greater pressure on gross margins; however,
the Company anticipates that it will be able to maintain comparable margins
prospectively through delivery of high quality service and reasonable increases
in its contract rates.

Selling, General and Administrative expenses ("SG&A"), decreased to $3,398,230
in 2003, from $6,299,390 in 2002. As a percentage of net revenue, SG&A decreased
to 32.4% in 2003, as compared with 41.8% in 2002. The aforementioned decrease in
revenue base has placed additional pressure on controlling overhead expenses;
however, the Company diligently seeks and pursues every available opportunity to
continue to reduce overhead.

Interest expense for 2003 was $134,239, as compared to $676,848 for 2002. The
decrease is primarily the result of a decrease in outstanding borrowings,
commensurate with the aforementioned decrease in revenue and, to a lesser
extent, a decrease in the interest rate on outstanding borrowings.

Year Ended May 31, 2002 Compared to Year Ended May 31, 2001

Net revenue for the year ended May 31, 2002 decreased $23,602,240 or 61.0% to
$15,077,134, compared to $38,679,374 for the year ended May 31, 2001. This
decrease was primarily attributable to the sale and closing of the Company's New

9

York and New Jersey facilities, as well as the closing of one of its
Pennsylvania facilities and, to a lesser extent, the elimination of poor margin
contracts in its remaining five facilities.

Gross profit margin percentages for the years ended May 31, 2002 and 2001 were
35.4% and 33.3%, respectively. The increase in the gross profit margin is
primarily attributable to an elimination of low profit margin contracts.

Selling, General and Administrative expenses as a percentage of net revenue was
41.8% in 2002, as compared with 26.2% in 2001. This percentage increase is
principally attributable to the aforementioned significant decrease in net
revenue. Although the Company continues to restructure its overhead in an effort
to achieve profitable operations, certain restructuring efforts have lagged
behind the corresponding decline in revenue.

Provision for doubtful accounts decreased from $5,531,259 in 2001 to a recovery
of $(19,229) in 2002. The Company has historically experienced a 1.5% to 2%
annual write off; however, following the decision to sell the New York and New
Jersey operations and discontinue business with the related payors, coupled with
the relocation of the Company's billing and collection function to New York, it
was believed that a significant portion of the related accounts receivable would
ultimately prove uncollectible. Accordingly, an additional provision of
approximately $4.7 million was made against related accounts receivable of
approximately $9.9 million. The principal reason for the Company's belief that
these accounts receivable would prove uncollectible was that upon deciding to
relocate the billing function, it was determined that the initial billing of
these services, principally Medicaid, lacked proper documentation necessary for
payment. Once this was discovered, the time period for which resubmissions could
be made had lapsed. The accounts receivable for which the fourth quarter
provision was made all arose during fiscal 2001. Management was unable to
foresee the potential losses from these accounts receivable prior to the end of
the fiscal year.

Interest expense for 2002 was $676,848, as compared to $773,432 for 2001. The
decrease is primarily the result of a decrease in the interest rate on
outstanding borrowings resulting from the Company's renegotiated credit facility
with a new lender and a reduction in the borrowings by the Company.

DISCONTINUED OPERATIONS

In February 1999, the Company formally adopted a plan to liquidate its Medicare
business being provided by one of its subsidiaries, Star Multi Care Services of
Florida, Inc d/b/a American Health Care Services. Decreasing utilization,
together with decreasing reimbursement rates and increasing costs, forced
management to cease operations with its providers July 1, 1999. The Company
liquidated its assets and discharged its liabilities through an assignment for
benefit of creditors under Florida state law, and the Company was formally
dissolved on August 23, 2000.

LIQUIDITY AND CAPITAL RESOURCES

As of May 31, 2003, cash and cash equivalents were $189,952, an increase of
$115,717 from $74,235 as of May 31, 2002. The Company intends to keep its
outstanding borrowings under its Credit Facility at a minimum and, therefore,
keeps its available cash at a minimum; however, large lockbox receipts in the
last few days of the year were unavailable for sweep by the Company's lender,
and remained as cash balances.

On August 1, 2001, the Company entered into a $2 million, 3-year credit facility
(the "Credit Facility") with G.E. Capital Healthcare Financial Services, Inc.
(formerly Heller Healthcare Finance, Inc.) The Credit Facility provides for the
Company to borrow up to 85% of eligible accounts receivable (as defined) that
are aged less than 150 days, at a borrowing rate of prime Plus 1%. Excluded from
the borrowing base were the accounts receivable from the New York and New Jersey
operations that were retained by the Company as part of the Premier transaction.
All of the assets of the Company collateralize the Credit Facility. The Company
is required to maintain tangible net worth (as defined) in excess of $(800,000).
At May 31, 2003, tangible net worth (as defined) was $(669,894).

At May 31, 2003, the outstanding loan balance was $1,907,298, as compared to
$990,254 at May 31, 2002.

The Company has experienced significant losses over the past several years.
Continued losses would ultimately exhaust the proceeds from the sale of the New
York and New Jersey operations and from the Company's Credit Facility; however,
significant sales and marketing efforts have finally resulted in a steady
increase in weekly revenue from approximately $185,000 per week as of August 31,
2002 to approximately $240,000 per week at May 31, 2003. As the cash flow of the
Company began to improve significantly, Stephen Sternbach, the Company's
President and Chief Executive Officer, and Matthew Solof, a former Director,
provided loans of an additional $350,000, to ensure the Company's continued
positive cash flow. The Company has since repaid $36,000 of these loans.

Further improving the cash flow of the Company was the satisfaction of the
Company's obligations under Medicare and New York State Medicaid settlements in
March 2003 and May 2003, respectively. Payments under these obligations amounted
to approximately $638,000 in 2003.

The Company believes that the recent turnaround in its profitability will enable
it to utilize its remaining deferred tax assets.

The Company does not anticipate any extraordinary material commitments for
capital expenditures during its current fiscal year.

The Company believes that can meet its cash requirements for the next twelve
months through its operations and its existing credit sources.

CONTRACTUAL OBLIGATIONS

The following table presents the Company's expected cash requirements for
contractual obligations outstanding as of May 31, 2003.

10

===============================================================================
PAYMENTS DUE BY PERIOD
===============================================================================
Less than 1-3 3-5 More than
Contractual Obligation Total 1 Year Years Years 5 Years
- ---------------------- ---------- ---------- ---------- ---------- ----------
- ---------------------- ---------- ---------- ---------- ---------- ----------
Operating leases $441,000 $197,000 $232,000 $12,000 --
- ---------------------- ---------- ---------- ---------- ---------- ----------
Other 702,000 281,000 421,000 -- --
- ---------------------- ---------- --------------------- ---------- ----------
- ---------------------- ---------- ---------- ---------- ---------- ----------
Total $1,143,000 $478,000 $653,000 $12,000 $ --
====================== ========== ========== ========== ========== ==========

INFLATION AND SEASONALITY

The rate of inflation was insignificant during the year ended May 31, 2003. In
the past, the effects of inflation on personnel costs have been offset by the
Company's ability to increase its charges for services rendered. The Company
anticipates that it will be able to continue to do so in the near future. The
Company continually reviews its costs in relation to the pricing of its
services.

The Company's business is not seasonal.


FORWARD LOOKING STATEMENTS

Certain statements in this report on Form 10-K constitute" forward-looking
statements" within the meaning of the Private Securities Litigation Reform Act
of 1995. These statements are typically identified by their inclusion of phrases
such as "the Company anticipates", "the Company believes" and other phrases of
similar meaning. These forward-looking statements are based on the Company's
current expectations. Such forward-looking statements involve known and unknown
risks, uncertainties, and other factors that may cause the actual results,
performance or achievements of the Company to be materially different from any
future results, performance or achievements expressed or implied by such
forward- looking statements. The potential risks and uncertainties that could
cause actual results to differ materially from the Company's expectations
include the impact of further changes in the Medicaid reimbursement system;
government regulation; health care reform; pricing pressures from third-party
payors, including managed care organizations; and changes in laws and
interpretations of laws or regulations relating to the health care industry.

GOVERNMENT REGULATION. As a home health care provider, the Company is subject to
extensive and changing state and federal regulations relating to the licensing
and certification of its offices and the sale and delivery of its products and
services. The federal government and Medicare fiscal intermediaries have become
more vigilant in their review of Medicare and Medicaid reimbursements to home
health care providers generally, and are becoming more restrictive in their
interpretation of those costs for which reimbursement will be allowed to such
providers. Changes in the law and regulations as well as new interpretations
enforced by the relevant regulatory agencies could have an adverse effect on the
Company's operations and the cost of doing business.

THIRD-PARTY REIMBURSEMENT AND MANAGED CARE. Because the Company is reimbursed
for its services primarily by the Medicaid programs, insurance companies,
managed care companies and other third-party payors, the implementation of
alternative payment methodologies for any of these payors could have an impact
on revenue and profit margins. Generally, managed care companies have sought to
contain costs by reducing payments to providers. Continued cost reduction
efforts by managed care companies could adversely affect the Company's results
of operations.

As Congress and state reimbursement entities assess alternative health care
delivery systems and payment methodologies, the Company cannot predict which
additional reforms may be adopted or what impact they may have on the Company.
Additionally, uncertainties relating to the nature and outcomes of health care
reforms have also generated numerous realignments, combinations and
consolidations in the health care industry that may also have an adverse impact
on the Company's business strategy and results of operations. The Company
expects continued industry consolidation.

BUSINESS CONDITIONS. The Company must continue to establish and maintain close
working relationships with physicians and physician groups, managed care
organizations, hospitals, clinics, nursing homes, social service agencies and
other health care providers. There can be no assurance that the Company will
continue to establish or maintain such relationships. The Company expects as
consolidation occurs that competition will intensify in future periods given the
increasing market demand for the type of services offered and the necessity to
maximize service volume due to anticipated operating margin decline.

ATTRACTION AND RETENTION OF EMPLOYEES. Maintaining quality managers and branch
administrators will play a significant part in the future success of the
Company. The Company's professional nurses and other health care personnel are
also key to the continued provision of quality care to the Company's patients.
The health care industry in general is experiencing both a professional and
paraprofessional shortage. The possible inability to attract and retain
qualified skilled management and sufficient numbers of credentialed health care
professionals and para-professionals could adversely affect the Company's
operations and quality of service.


ITEM 9A. CONTROLS AND PROCEDURES.

The Registrant carried out an evaluation, under the supervision and with the
participation of the Registrant's management, including the Registrant's Chief
Executive Officer and Chief Financial Officer, of the effectiveness of the
Registrant's disclosure controls and procedures, as defined in Rules 13a-15(e)
and 15d-15(e) of the Securities and Exchange Act of 1934. Based on that

11

evaluation, the Chief Executive Officer and Chief Financial Officer have
concluded that the Registrant's disclosure controls and procedures as of May 31,
2003 were effective to ensure that information required to be disclosed by the
Registrant in reports that it files or submits under the Securities Exchange Act
of 1934 is recorded, processed, summarized and reported within the time periods
specified in Securities and Exchange Commission's rules and forms.

There were no changes in the Registrant's internal control over financial
reporting that occurred during the quarter ended May 31, 2003 that have
materially affected, or are reasonably likely to materially affect, the
Registrant's internal control over financial reporting.


PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS;
COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT

STEPHEN STERNBACH

Stephen Sternbach has been the Chairman of the Board of Directors, President and
Chief Executive Officer of the Company since 1987. From 1978 to 1986, Mr.
Sternbach was associated with Automated Data Processing, Inc. ("ADP"), a
provider of information services where he held several marketing positions and
ultimately the position of Director of Sales. Mr. Sternbach has served on the
Board of Trustees of the Long Island Chapter of the National Multiple Sclerosis
Society since 1996. Mr. Sternbach earned a Masters Degree in Public
Administration from Syracuse University and a B.A. in Industrial Relations &
Personnel Administration from Ithaca College.

CHARLES BERDAN

Charles Berdan became a director of the Company in April 1994. Presently, Mr.
Berdan is a sales executive with People Management located in South Plainfield,
New Jersey. Prior thereto, he served as Regional Sales Manager for LearnFrame,
an online training company. From April 1994 through June 1998, Mr. Berdan has
served as a sales executive for Automatic Data Processing, Inc., a provider of
information services. From January 1993 to September 1993, Mr. Berdan was a Vice
President of the Senior Bulletin, a newspaper, which the Company purchased in
September 1993. Mr. Berdan is a Class III director and will stand for
re-election to the Board of Directors at the 2004 Annual Meeting of
Shareholders.

MATTHEW SOLOF

Matthew Solof has been a director of the Company since November 1992. Since
1991, he has been the President and Chief Executive Officer of AMI Group, a real
estate development and acquisition company, and President and Chief Executive
Officer of Mercantile Mortgage Association, a mortgage lending company. Since
1996 he has been President and Chief Executive Officer of Landco Mortgage
Bankers, Inc., a New York State licensed mortgage banker. From 1983 to 1992, Mr.
Solof was a trader at IRV Companies, a firm which specialized in oil trading,
and from 1981 to 1991, he was President and Chief Executive Officer of Matthew
Solof Trading Company, a firm which also specializes in oil trading. Mr. Solof
resigned from the Board of directors in September 2002.

GARY L. WEINBERGER

Gary L. Weinberger has been engaged in the private practice of orthodontics for
more than 20 years. In addition, Dr. Weinberger is engaged as a consultant on
financial planning and management. Dr. Weinberger is a member of the
International Board of Standards and Practices for Financial Planners, the
International Association of Financial Planners, and the American Association of
Orthodontists. Mr. Weinberger resigned from the Board of Directors in July 2002.

MEETINGS OF THE BOARD OF DIRECTORS
- ----------------------------------
During the Company's last fiscal year, its Board of Directors held one (1)
meeting and acted four (4) times through unanimous written consent.

As there are presently only two members of the Board of Directors, the Stock
Option Committee, the Audit Committee, the Compliance and the Compensation of
the Board of Directors were not elected by the Board of Directors this past
fiscal year.

The Board of Directors has no standing nominating committee.

Each incumbent director attended at least 75% of the meetings of the Board of
Directors and the committee on which he served which were held while he was
serving as a director and/or committee member during the Company's last fiscal
year.

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
- -----------------------------------------------------------
No members of the Compensation Committee have a relationship that would
constitute an interlocking relationship with executive officers or directors of
another entity.
12

Section 16(a) of the Securities Exchange Act of 1934 requires the Company's
officers and directors, and persons who own more than ten percent of its common
stock, to file reports of ownership and changes of ownership with the Securities
and Exchange Commission ("SEC") and each exchange on which the Company's
securities are registered. Officers, directors and greater than ten-percent
shareholders are required by SEC regulation to furnish the Company with copies
of all ownership forms they file.

Based solely on its review of the copies of such forms received by it, or
written representations from certain persons that no Form 5 was required for
those persons, the Company believes that, during the year ended May 31, 2003,
its officers, directors and greater than ten-percent shareholders complied with
all applicable Section 16 filing requirements.


ITEM 11. EXECUTIVE COMPENSATION

SUMMARY COMPENSATION TABLE


Name and Annual Restricted
Principal Compensation Stock Securities LTIP All Other
Position Year Salary($) Bonus($) Awards Underlying Options(#) Payments($) Compensation
- -------- ---- --------- -------- ------ --------------------- ----------- ------------

Stephen Sternbach 2003 $275,529 $0 -- -- 0 $0
Chief Executive Officer, 2002 $275,529 $0 -- -- 100,000 $32,660.40 (1)
President and 2001 $289,956 $0 -- -- 0 $0
Chairman of the Board

David Schoenberg 2003 $109,231
Chief Financial Officer 2002 $25,000
2001 $0

___________________

(1) Represents forgiveness of note owed to Company.


Option/SAR Grants in Last Fiscal Year

Potential Realized
Value at Assumed
Annual Rates of
Stock Price
Appreciation
for Option Term
- ---------------------------------------------------------------------------------------------
(a) (b) (c) (d) (e) (f) (g)
Number of % of Total
Securities Options/SARs
Underlying Granted to Exercise
Options/SARs Employees in or Base Expiration
Name Granted (#) Fiscal Year Price ($/Sh) Date 5% 10%
- ---------------------------------------------------------------------------------------------

David Schoenberg 50,000 100% $.14 10/27/07 $8,933 $11,274



Aggregated Option Exercises in Last Fiscal Year
and Fiscal Year-End Option Values

The following table contains information concerning the number and value, at May
31, 2003, of the exercised and unexercised options held by Mr. Sternbach.


Name Shares Value Number of Securities Value of Unexercised
Acquired Realized Underlying Unexercised In-the-Money Options Held
on ($) Options Held at Fiscal at Fiscal Year-End (1)
Exercise Year-End (Exercisable/Unexercisable)
(#) (Exercisable/Unexercisable)
- ----------------- -------- -------- --------------------------- ---------------------------

Stephen Sternbach 0 0 151,112/0 $0

David
Schoenberg
0 0 0/50,000 0
- ----------------- -------- -------- --------------------------- ---------------------------


(1) Fair market value of underlying securities (the closing price of the
Company's Common Stock on the NASD OTC Bulletin Board) at fiscal year end
(May 31, 2003), minus the then effective exercise price.


EMPLOYMENT AGREEMENTS AND TERMINATION OF EMPLOYMENT AND CHANGE IN CONTROL
ARRANGEMENTS.

The Company has an employment agreement with Stephen Sternbach dated as of
December 3, 1995 (the "Sternbach Employment Agreement"). The Sternbach
Employment Agreement has a term of five years and provides for an initial annual
salary of $250,000 (subject to annual increase by the amount of the increase in
the Consumer Price Index from the immediate preceding year) plus a bonus of 6%
of the Company's net profit before taxes in excess of $1,200,000, not to exceed
an aggregate annual bonus of $500,000. The Sternbach Employment Agreement
provides that after a Change in Control (as defined in the Sternbach Employment
Agreement) of the Company has occurred, if either Mr. Sternbach terminates his
employment within six months after he has obtained actual knowledge of the
Change in Control or the Company (or any successor thereto) terminates his
employment with the Company within one year after the Change in Control, Mr.
Sternbach will be entitled to receive (i) his salary, bonuses, awards,
perquisites and benefits including, without limitation, benefits and awards
under the Company's stock option plans and pension and retirement plans and
programs, accrued through the date Mr. Sternbach's employment with the Company
is terminated and (ii) a lump-sum payment in cash equal to 2.99 times Mr.
Sternbach's base amount.
13

On June 21, 2000, the Board of Directors of the Company renewed the employment
agreement with Stephen Sternbach originally dated as of December 3, 1995, as
amended, for an additional five year term (the "Renewed Sternbach Employment
Agreement"). The Renewed Sternbach Employment Agreement provides for an annual
salary of $280,813.52, his base salary prior to renewal (subject to annual
increase by the amount of the increase in the Consumer Price Index from the
immediate preceding year) plus a bonus of 6% of the Company's net profit before
taxes in excess of $1,200,000. The Renewed Sternbach Employment Agreement
provides that after a Change in Control (as defined in the Sternbach Employment
Agreement) of the Company has occurred, if either Mr. Sternbach terminates his
employment within six months after he has obtained actual knowledge of the
Change in Control or the Company (or any successor thereto) terminates his
employment with the Company within one year after the Change in Control, Mr.
Sternbach will be entitled to receive (i) his salary, bonuses, awards,
perquisites and benefits including, without limitation, benefits and awards
under the Company's stock option plans and pension and retirement plans and
programs, accrued through the date Mr. Sternbach's employment with the Company
is terminated and (ii) a lump-sum payment in cash equal to 2.99 times Mr.
Sternbach's base amount.

On October 6, 2001, Mr. Sternbach voluntarily waived the cost of living increase
that was scheduled to go into affect and further reduced his salary to $275,500
from $290,080. Additionally, in October 2002, he again waived the cost of living
increase that was scheduled to go into affect.

In addition, the Renewed Sternbach Employment Agreement terminated the
Non-Qualified Retirement and Death Benefit Agreement dated February 1, 1994
Instead, the Renewed Sternbach Employment Agreement provides for an annual
contribution by the Company to an investment vehicle of Mr. Sternbach's choice
equal to ten percent (10%) of his wages and will no longer be deemed deferred
compensation. Additionally, the Company shall continue to pay the premiums of a
life insurance policy, owned by Mr. Sternbach, insuring his life for $1.2
million. The cash value of this policy was assigned to Mr. Sternbach.

The Company and Mr. Sternbach are also parties to a Consulting Agreement (the
"Sternbach Consulting Agreement") pursuant to which the Company has agreed to
retain Mr. Sternbach as a consultant for a period of two years from the time
that his employment with the Company terminates. Pursuant to the Sternbach
Consulting Agreement, the Company has agreed to pay Mr. Sternbach $150,000 per
year and he will be entitled to participate in the health insurance and similar
benefits which the Company provides to any of its other consultants.

COMPENSATION COMMITTEE REPORT
- -----------------------------

Overview and Philosophy
-----------------------
The Company's executive compensation philosophy (which is intended to apply
to all members of the Company's management, including its Chief Executive
Officer) is to provide competitive levels of compensation, integrate
managements' pay with achievement of the Company's performance goals, reward
above average corporate performance, recognize individual initiative and
achievement and assist the Company in attracting and retaining qualified
management.

The objectives of the Company's executive compensation program are to:

Support the achievement of desired Company performance.
* Provide compensation that will attract and retain superior talent and
reward performance.

The executive compensation program provides an overall level of
compensation opportunity that is competitive within the health care industry, as
well as with a broader group of companies of comparable size and complexity.

Executive Officer Compensation
------------------------------
The Company's executive officer compensation is comprised of base salary,
annual cash bonus and long-term incentive compensation in the form of stock
options and various benefits, including medical plans generally available to
employees of the Company.

It is the philosophy of the Company that compensation of executive officers
should be closely aligned with the financial performance of the Company.
Accordingly, benefits are provided through stock option incentives and bonuses
which are generally consistent with the goal of coordinating the rewards to
management with a maximization of shareholder return. In reviewing Company
performance, consideration is given to the Company's earnings. Also taken into
account are external economic factors that effect results of operations. An
attempt is also made to maintain compensation within the range of that afforded
like executive officers at companies whose size and business is comparable to
that of the Company.

CEO Compensation
----------------
In the case of Stephen Sternbach, the Chief Executive Officer, the Board of
Directors evaluates the Company's mid and long range strategic planning and its
implementation as well as the considerations impacting the compensation of
executive officers generally which are described above. Mr. Sternbach was
awarded a bonus of $25,000 for the year ended May 31, 2000, that will be paid in
fiscal 2000-2001.
14

Benefits
--------
The Company endorses the position that equity ownership by management is
beneficial in aligning managements' and shareholders' interest in the
enhancement of shareholder value. Stock options were granted at exercise prices
equal to the market value of the Company's Common Stock on the date of grant.

The Company provides to executive officers medical benefits that generally
are available to Company employees. The amount of perquisites, as determined in
accordance with the rules of the Securities and Exchange Commission relating to
executive compensation, did not exceed 10% of salary for fiscal 2000.

COMPENSATION OF DIRECTORS

The Company's non-employee directors are paid a fee of $750 for each Board
of Directors meeting that they attend. They are not paid any additional fee for
serving on any committees of the Board of Directors.

PERFORMANCE GRAPH
- -----------------

Set forth below is a graph comparing the yearly change in the cumulative
shareholder return of the Company's Common Stock with the National Association
of Securities Dealers Automated Quotation Market Index and a peer group index of
five competing companies for the same period. The comparison assumes $100 was
invested at the close of business on May 31, 1998 in the Company's Common Stock
and in each of the comparison groups, and assumes reinvestment of dividends. The
Company paid no cash dividends during the periods.


COMPARISON OF CUMULATIVE TOTAL RETURN OF ONE OR MORE
COMPANIES, PEER GROUPS, INDUSTRY INDEXES AND/OR BROAD MARKETS


----------------------- FISCAL YEAR ENDING ---------------------
COMPANY/INDEX/MARKET 5/29/1998 5/28/1999 5/31/2000 5/31/2001 5/31/2002 5/30/2003

Star Multi Care Services 100.00 51.28 25.64 6.34 3.15 .23
Customer Selected Stock List 100.00 65.57 36.85 73.18 121.30 165.18
NASDAQ Market Index 100.00 137.77 196.90 125.59 96.44 95.78


The Custom Selected Peer Stock List is made up of the following securities:

ALLIED HEALTHCARE INTL
GENTIVA HEALTH SVCS
NATIONAL HOME HLTH CARE
NEW YORK HEALTH CARE INC



ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

Set forth below is the ownership of the Company's Common Stock at September
12, 2003: (i) the only persons or groups who were owners of record or were known
by the Company to beneficially own on September 12, 2003 more than 5% of the
outstanding shares of Common Stock; (ii) each director and nominee for director
of the Company; (iii) each executive officer named in the Summary Compensation
Table under the caption "Executive Compensation" below; and (iv) all directors
and executive officers of the Company as a group. The Company understands that,
except as noted below, each beneficial owner has sole voting and investment
power with respect to all shares attributable to such owner.

15

Amount and Nature
Name and Address of Beneficial Percent
of Beneficial Owner Ownership* of Class (1)
- ---------------------------------- ----------------- -----------
Stephen Sternbach
c/o Star Multi Care Services, Inc.
33 Walt Whitman Road
Huntington Station, NY 11746 7,810,059 (2) 47.7%
- ---------------------------------- ----------------- -----------
Charles Berdan
c/o Star Multi Care Services, Inc.
33 Walt Whitman Road 18,502 (3) .1%
Huntington Station, NY 11746
- ---------------------------------- ----------------- -----------
Matthew Solof
33 Fairbanks Boulevard 7,772,418 (4) 47.9%
Woodbury, NY 11797
- ---------------------------------- ----------------- -----------
Gary L. Weinberger
c/o Star Multi Care Services, Inc.
33 Walt Whitman Road 20,002 (3) .1%
Huntington Station, NY 11746
- ---------------------------------- ----------------- -----------
David Schoenberg
c/o Star Multi Care Services, Inc.
33 Walt Whitman Road
Huntington Station, NY 11746 50,000 (5) .3%
- ---------------------------------- ----------------- -----------
All directors and executive
officers of the Company as a group
(5 persons) 15,670,981 95.4%

__________

* All share amounts in this table have been adjusted to take into account the
stock dividends effectuated on May 30, 1995, January 12, 1996 and November
4, 1996, respectively, and the 1 for 3 reverse stock split effective on
December 13, 1999 and on January 25, 2001.
(1) Shares subject to options are considered outstanding only for the purpose
of computing the percentage of outstanding Common Stock which would be
owned by the optionee if the options were so exercised, but (except for the
calculation of beneficial ownership by all executive officers and directors
as a group) are not considered outstanding for the purpose of computing the
percentage of outstanding Common Stock owned by any other person.
(2) Includes 15,521 shares of the Company's Common Stock owned by the Stephen
Sternbach Family Trust and by his spouse; Mr. Sternbach disclaims
beneficial ownership with respect to these shares. Also includes 151,112
shares of the Company's Common Stock which Mr. Sternbach has a currently
exercisable option to purchase pursuant to the Company's 1992 Stock Option
Plan.
(3) Exclusively includes stock options granted the Company's common stock
granted under the Company's 1997 Non-Employee Director Stock Option Plan.
(4) Includes options to purchase 30,002 shares of the Company's common stock
granted under the Company's 1997 Non-Employee Director Stock Option Plan.
(5) Exclusively includes stock options granted pursuant to the Company's 1992
Stock Option Plan.

16

Equity Compensation Plan Information


Equity Number of Weighted-average Number
Compensation Plans securities to be exercise price of securities
Approved by issued upon outstanding remaining
Security Holders exercise of options, warrants available for
outstanding and rights future issuance
options, warrants under equity
and rights compensation plans
(excluding securities
reflected in column (a)

(a) (b) (c)

Star Multi Care Services, Inc. 291,822 $2.63 54,599
1992 Stock Incentive Plan

1995 Star Multi Care
Services Employee Stock
Purchase Plan 0 0 35,515

1997 Star Multi Care
Services Non-employee
Director 70,614 $3.50 10,611



ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

On April 30, 2001, Stephen Sternbach, Chief Executive Officer of the
Company, loaned the Company $100,000. Mr. Sternbach's loan was secured by the
assets of the Company and his security interest was subordinated to the
Company's primary lender. The term of the loan was for one year with annual
interest at the rate of 14%. On May 17, 2002, this promissory note was amended
whereby: (i) the principal amount loaned was increased to $125,000 and amended
to permit future additional borrowings; (ii) the term was extended for an
additional twelve months from May 17, 2002; and (iii) the interest rate was
lowered to 8%. Additional loans to the Company have increased the loan balance
to $315,000.

On August 26, 2002, Matthew Solof, a shareholder of the Company loaned
the Company $50,000. Mr. Solof's loan was secured by the assets of the Company
and his security interest was subordinated to the Company's primary lender. The
term of the loan was for one year with interest at the rate of 8% per annum.
Additional loans to the Company have increased the loan balance to $250,000.



17

STAR MULTI CARE SERVICES, INC.
------------------------------
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
------------------------------------------




Page
----

Independent Auditors' Report F-2

Consolidated balance sheets as of May 31, 2003 and 2002 F-3

Consolidated statements of operations for the three years ended
May 31, 2003 F-4

Consolidated statement of shareholders' equity
for the three years ended May 31, 2003 F-5

Consolidated statements of cash flows for the three years ended
May 31, 2003 F-6

Notes to consolidated financial statements F-7 - F-21

















F-1


Independent Auditors' Report
----------------------------



Board of Directors and Shareholders
Star Multi Care Services, Inc.
Huntington, New York

We have audited the accompanying consolidated balance sheets of Star Multi Care
Services, Inc. as of May 31, 2003 and 2002 and the related consolidated
statements of operations, shareholders' equity and cash flows for each of the
three years in the period ended May 31, 2003. These financial statements are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these financial statements based on our audits.

We conducted our audits in accordance with auditing standards generally accepted
in the United States of America. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the consolidated financial position of Star Multi Care
Services, Inc. as of May 31, 2003 and 2002, and the consolidated results of its
operations and its cash flows for each of the three years in the period ended
May 31, 2003, in conformity with accounting principles generally accepted in the
United States of America.






HOLTZ RUBENSTEIN & CO., LLP

Melville, New York
August 1, 2003


F-2


STAR MULTI CARE SERVICES, INC.
------------------------------
CONSOLIDATED BALANCE SHEETS
---------------------------

May 31,
--------------------------------
2003 2002
------------ ------------

ASSETS
------

CURRENT ASSETS:
Cash and cash equivalents $ 189,952 $ 74,235
Accounts receivable, net of allowance for doubtful
accounts of $315,000 and $200,000 at May 31,
2003 and 2002, respectively 1,976,349 1,613,540
Prepaid expenses and other current assets 100,534 148,755
Deferred income taxes 199,235 206,000
------------ ------------
Total current assets 2,466,070 2,042,530

PROPERTY AND EQUIPMENT, net 280,573 572,859
GOODWILL 1,307,444 1,307,444
OTHER INTANGIBLE ASSETS, net 327,735 351,859
DEFERRED INCOME TAXES 356,000 1,404,000
OTHER ASSETS 20,201 50,647
------------ ------------

$ 4,758,023 $ 5,729,339
============ ============
LIABILITIES AND SHAREHOLDERS' EQUITY
------------------------------------

CURRENT LIABILITIES:
Revolving credit line $ 1,907,298 $ 990,254
Accrued payroll and related taxes 273,058 234,194
Accounts payable 299,097 586,629
Accrued expenses 748,285 1,227,631
Due Medicare -- 350,000
Due officer 315,000 125,000
Due to shareholder 250,000 --
------------ ------------
Total current liabilities 3,792,738 3,513,708
------------ ------------


COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS' EQUITY:
Convertible preferred stock, 5,000,000 shares authorized;
$1.00 par value, -0- and 325 shares issued, respectively -- 325
Common stock, $.001 par value, 20,000,000 shares authorized;
16,208,676 and 1,024,021 shares issued, respectively 16,209 1,024
Additional paid-in capital 21,807,003 21,669,864
Deficit (20,467,236) (19,064,891)
Treasury stock, 26,367 common shares at May 31, 2003
and 2002, respectively, at cost (390,691) (390,691)
------------ ------------
Total shareholders' equity 965,285 2,215,631
------------ ------------

$ 4,758,023 $ 5,729,339
============ ============

See notes to consolidated financial statements

F-3

STAR MULTI CARE SERVICES, INC.
------------------------------
CONSOLIDATED STATEMENTS OF OPERATIONS
-------------------------------------

Years Ended May 31,
------------------------------------------------
2003 2002 2001
------------ ------------ ------------

REVENUE, net $ 10,474,782 $ 15,077,134 $ 38,679,374
------------ ------------ ------------

OPERATING EXPENSES:
Cost of revenue 6,748,346 9,740,216 25,794,229
Selling, general and administrative 3,398,228 6,299,390 10,127,989
Depreciation and amortization 309,904 788,412 1,006,635
Provision for (recovery of) doubtful accounts 136,250 (19,229) 5,531,259
Impairment of assets to be disposed -- -- 4,205,000
------------ ------------ ------------
10,592,728 16,808,789 46,665,112
------------ ------------ ------------

OPERATING LOSS (117,946) (1,731,655) (7,985,738)
------------ ------------ ------------

OTHER INCOME (EXPENSES):
Gain on the sale of business -- 312,671 --
Interest expense, net (134,239) (676,848) (773,432)
------------ ------------ ------------
(134,239) (364,177) (773,432)
------------ ------------ ------------

LOSS BEFORE PROVISION FOR INCOME TAXES (252,185) (2,095,832) (8,759,170)

PROVISION FOR INCOME TAXES 1,076,000 542,000 --
------------ ------------ ------------
LOSS FROM CONTINUING OPERATIONS AND
BEFORE EXTRAORDINARY ITEM (1,328,185) (2,637,832) (8,759,170)
------------ ------------ ------------
DISCONTINUED OPERATIONS:
Loss from discontinued operations
tax benefit of $-0-, $-0-, and $-0- -- -- (1,000,000)

EXTRAORDINARY ITEM:
Gain on extinguishment of debt, net of income
tax of $1,040,000 -- 1,553,324 --
------------ ------------ ------------

NET LOSS $ (1,328,185) $ (1,084,508) $ (9,759,170)
============ ============ ============

LOSS PER COMMON SHARE:
Continuing operations $ (0.37) $ (3.21) $ (14.21)
Discontinued operations -- -- (1.62)
Extraordinary item -- 1.85 --
------------ ------------ ------------

Net loss $ (0.37) $ (1.36) $ (15.83)
============ ============ ============
WEIGHTED AVERAGE NUMBER OF
SHARES OUTSTANDING:
Basic 3,766,911 841,902 619,005
============ ============ ============

Diluted 3,766,911 841,902 619,005
============ ============ ============

See notes to consolidated financial statements

F-4


STAR MULTI CARE SERVICES, INC.
------------------------------
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
-----------------------------------------------

Common Stock Preferred Stock
--------------------------- ----------------------------
Par Par
Shares Value Shares Value
------------ ------------ ------------ ------------


Balance, June 1, 2000 613,222 $ 613 575 $ 575

Exercise of stock options 3,334 3 -- --
Conversion of preferred stock 83,024 83 (120) (120)
Dividends to preferred shareholders 1,829 2 -- --
Comprehensive loss -- -- -- --
Comprehensive loss -- -- -- --
------------ ------------ ------------ ------------


Balance, May 31, 2001 701,409 701 455 455

Shares issued under Employee Stock Purchase Plan 39,326 39 -- --
Conversion of preferred stock 210,670 211 (130) (130)
Dividends to preferred shareholders 72,616 73 -- --
Other -- -- -- --
Net loss -- -- -- --
Comprehensive loss -- -- -- --
------------ ------------ ------------ ------------


Balance, May 31, 2002 1,024,021 1,024 325 325

Conversion of Series A to Series B preferred stock -- -- 152 152
Conversion of preferred stock 15,184,655 15,185 (477) (477)
Dividends to preferred shareholders -- -- -- --
Net loss -- -- -- --
Comprehensive loss -- -- -- --
------------ ------------ ------------ ------------


Balance, May 31, 2003 16,208,676 $ 16,209 -- $ --
============ ============ ============ ============


Treasury Stock
---------------------------
Paid in Subscription
Capital Receivable Deficit Shares Value
------------ ------------ ------------ ------------ ------------

Balance, June 1, 2000 $ 21,563,990 $ (397,782) $ (8,118,059) 26,367 $ (390,691)

Exercise of stock options 13,747 -- -- -- --
Conversion of preferred stock 37 -- -- -- --
Dividends to preferred shareholders 7,543 -- (40,499) -- --
Comprehensive loss -- -- -- -- --
Comprehensive loss -- -- (9,759,170) -- --
------------ ------------ ------------ ------------ ------------


Balance, May 31, 2001 21,585,317 (397,782) (17,917,728) 26,367 (390,691)

Shares issued under Employee Stock Purchase Plan 62,608 -- -- -- --
Conversion of preferred stock (81) -- -- -- --
Dividends to preferred shareholders 22,020 -- (62,655) -- --
Other -- 397,782 -- -- --
Net loss -- -- (1,084,508) -- --
Comprehensive loss -- -- -- -- --
------------ ------------ ------------ ------------ ------------


Balance, May 31, 2002 21,669,864 -- (19,064,891) 26,367 (390,691)

Conversion of Series A to Series B preferred stock 151,847 -- -- -- --
Conversion of preferred stock (14,708) -- -- -- --
Dividends to preferred shareholders -- -- (74,160) -- --
Net loss -- -- (1,328,185) -- --
Comprehensive loss -- -- -- -- --
------------ ------------ ------------ ------------ ------------


Balance, May 31, 2003 $ 21,807,003 $ -- $(20,467,236) 26,367 $ (390,691)
============ ============ ============ ============ ============


Total
Shareholders' Comprehensive
Equity Loss
------------ ------------

Balance, June 1, 2000 $ 12,658,646 $ --

Exercise of stock options 13,750 --
Conversion of preferred stock -- --
Dividends to preferred shareholders (32,954) --
Comprehensive loss -- --
Comprehensive loss (9,759,170) (9,759,170)
------------ ------------
$ (9,759,170)
============
Balance, May 31, 2001 2,880,272

Shares issued under Employee Stock Purchase Plan 62,647 $ --
Conversion of preferred stock -- --
Dividends to preferred shareholders (40,562) --
Other 397,782 --
Net loss (1,084,508) --
Comprehensive loss -- (1,084,508)
------------ ------------
$ (1,084,508)
============
Balance, May 31, 2002 2,215,631

Conversion of Series A to Series B preferred stock 151,999 $ --
Conversion of preferred stock -- --
Dividends to preferred shareholders (74,160) --
Net loss (1,328,185) --
Comprehensive loss -- (1,328,185)
------------ ------------
$ (1,328,185)
============
Balance, May 31, 2003 $ 965,285
============

See notes to consolidated financial statements

F-5

STAR MULTI CARE SERVICES, INC.
------------------------------
CONSOLIDATED STATEMENTS OF CASH FLOWS
-------------------------------------

Years Ended May 31,
--------------------------------------------
2003 2002 2001
------------ ------------ ------------

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss $ (1,328,185) $ (1,084,508) $ (9,759,170)
------------ ------------ ------------
Adjustments to reconcile net loss to net cash
(used in) provided by operating activities:
Provision for doubtful accounts 136,250 -- 5,531,259
Depreciation and amortization 309,904 788,412 1,006,635
Deferred income taxes 1,054,765 1,435,000 (41,000)
Loss on disposal of assets 6,506 -- --
Extraordinary item - gain on extinguishment of debt -- (2,593,324) --
Gain on sale of business -- (312,671) --
Impairment of assets to be disposed -- -- 4,205,000
Changes in operating assets and liabilities:
(Increase) decrease in assets:
Accounts receivable (499,059) 3,005,431 (1,875,710)
Prepaid expenses and other current assets 48,221 130,157 4,677
Other assets 30,446 167,256 2,325
Increase (decrease) in liabilities:
Accounts payable and accrued expenses (650,175) (2,416,868) 997,391
Due Medicare (350,000) (650,000) 1,000,000
Other liabilities -- (311,828) (623,393)
------------ ------------ ------------
Total adjustments 86,858 (758,435) 10,207,184
------------ ------------ ------------
Net cash (used in) provided by operating activities (1,241,327) (1,842,943) 448,014
------------ ------------ ------------

CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of business, net -- 5,001,274 --
Purchase of intangibles -- -- (108,446)
Purchase of property and equipment -- (25,193) (62,704)
------------ ------------ ------------
Net cash provided by (used in) investing activities -- 4,976,081 (171,150)
------------ ------------ ------------

CASH FLOWS FROM FINANCING ACTIVITIES:
Net borrowings (repayments) on revolving credit line 917,044 (2,857,061) (1,001,568)
(Repayment of) proceeds from note payable -- (300,000) 300,000
Proceeds from officer's loan 190,000 25,000 100,000
Proceeds from issuance of stock under option plans -- 62,647 13,750
Proceeds from shareholder loans 250,000 -- --
------------ ------------ ------------
Net cash provided by (used in) financing activities 1,357,044 (3,069,414) (587,818)
------------ ------------ ------------

NET INCREASE (DECREASE) IN CASH AND CASH
EQUIVALENTS 115,717 63,724 (310,954)

CASH AND CASH EQUIVALENTS, beginning of year 74,235 10,511 321,465
------------ ------------ ------------

CASH AND CASH EQUIVALENTS, end of year $ 189,952 $ 74,235 $ 10,511
============ ============ ============
SUPPLEMENTAL DISCLOSURE:
Income taxes paid $ -- $ 22,000 $ 54,000
============ ============ ============

Interest paid $ 143,000 $ 719,000 $ 774,000
============ ============ ============

See notes to consolidated financial statements

F-6

STAR MULTI CARE SERVICES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE YEARS ENDED MAY 31, 2003

1. Summary of Significant Accounting Policies:
------------------------------------------
a. Nature of operations
--------------------

The Company is principally engaged in providing temporary health care
personnel, including registered nurses, licensed practical nurses, certified
home health aides, nurses aides and respiratory therapists to hospitals, nursing
homes, extended care facilities and in-home patients in Florida, Ohio, New
Jersey, Pennsylvania, upstate New York and the New York City metropolitan area.

On August 31, 2001, the Company sold to Premier Home Health Care
Services, Inc. ("Premier") certain assets related to the home health care
operation of the Company's New Jersey business, and certain assets related to
its home health care operations in New York. (See Note 17.)

During fiscal 2002, the Company negotiated a new credit facility and
sold its businesses in New York and New Jersey, in an effort to reduce its
working capital shortfall. In addition, the Company has continued to restructure
and consolidate its operations, in an effort to reduce operating expenses. The
continued operations of the Company are dependent upon the Company's ability to
generate increased revenue and improved operating results, or by obtaining
additional debt financing or equity funds to meet working capital needs.

b. Principles of consolidation
---------------------------
The consolidated financial statements include the accounts of Star
Multi Care Services, Inc. and its subsidiaries (the "Company"), all of which are
wholly-owned. All significant intercompany transactions and accounts have been
eliminated.

c. Revenue recognition and allowance for doubtful accounts
-------------------------------------------------------
Net patient service revenue is reported at estimated net realizable
amounts from patients, third-party payors, and others for services rendered and
includes estimated retroactive revenue adjustments due to future audits,
reviews, and investigations. Retroactive adjustments are considered in the
recognition of revenue on an estimated basis in the period the related services
are rendered, and such amounts are adjusted in future periods as adjustments
become known or as years are no longer subject to such audits, reviews and
investigations. A provision for doubtful accounts is made for revenue estimated
to be uncollectible and is adjusted based upon management's evaluation of
current industry conditions, historical collection experience and other relevant
factors which, in the opinion of management, deserve recognition in estimating
the allowance for doubtful accounts.

Under Medicaid, Medicare and other cost-based reimbursement programs,
the Company is reimbursed for services rendered to covered program patients as
determined by reimbursement formulas. Revenue from Medicaid programs account for
approximately 65%, 70% and 63% of the Company's net patient revenue for the
years ended May 31, 2003, 2002 and 2001, respectively. Laws and regulations
governing the Medicaid programs are extremely complex and subject to
interpretation. As a result, there is at least a reasonable possibility that
recorded estimates will change by a material amount in the near term.

F-7

1. Summary of Significant Accounting Policies: (Cont'd)
------------------------------------------
d. Net income (loss) per common share
----------------------------------
The basic calculation is determined by dividing net income (loss)
attributable to common shares outstanding (the basic numerator) by the weighted
average number of common shares outstanding (the basic denominator) during the
period.

The diluted calculation is determined by adjusting the basic
numerator for any changes in income or loss that would result from the assumed
exercise of potentially issued common shares. Additionally, the basic
denominator is increased to include the additional number of common shares that
would be outstanding if the potentially issued common shares had been issued, if
dilutive. Potentially issued common shares, consisting of options, are not
included in this calculation where the effect of the inclusion would be
anti-dilutive. The treasury stock method is used to reflect the dilutive effect
of outstanding options and warrants. For the years ended May 31, 2003, 2002 and
2001, the effect of any common stock equivalents would have been anti-dilutive.

Net loss available to common shareholders was computed as follows:


Years Ended May 31,
-------------------------------------------
2003 2002 2001
----------- ----------- -----------

Net loss $(1,328,185) $(1,084,508) $(9,759,170)
Dividends on preferred shares (74,160) (62,655) (40,499)
----------- ----------- -----------
Net loss available to common
shareholders $(1,402,345) $(1,147,163) $(9,799,669)
=========== =========== ===========


e. Property and equipment
----------------------
Property and equipment is recorded at cost. The carrying amount of
assets and related accumulated depreciation and amortization are removed from
the accounts when such assets are disposed of, and the resulting gain or loss is
included in operations. Depreciation is computed by the straight-line method
over the estimated useful lives of the assets. Leasehold improvements are
amortized over the shorter of the remaining life of the lease or the life of the
improvements.

f. Goodwill and intangible assets
------------------------------
In June 2002, the Company adopted Statement of Financial Accounting
Standards ("SFAS") No. 141, "Business Combinations" and SFAS No. 142, "Goodwill
and Intangible Assets." SFAS No. 141 requires the use of the purchase method of
accounting and prohibits the use of the pooling-of-interests method of
accounting for business combinations initiated after June 30, 2001. SFAS No. 141
also requires that the Company recognize acquired intangible assets apart from
goodwill if the acquired intangible assets meet certain criteria. It also
requires, upon adoption of SFAS No. 142, that the Company reclassify, if
necessary, the carrying amounts of intangible assets and goodwill based on the
criteria of SFAS No. 141.

SFAS No. 142 requires, among other things, that companies no longer
amortize goodwill, but instead test goodwill for impairment at least annually.
In addition, SFAS No. 142 requires that the Company identify reporting units for
the purpose of assessing potential future impairments of goodwill, reassess the
useful lives of other existing recognized intangible assets and cease
amortization of intangible assets with an indefinite useful life. The Company's
previous business combinations were accounted for by using the purchase method
and, as of June 2002, the net carrying amount of goodwill from prior purchase
transactions was approximately $1,307,000.

F-8

1. Summary of Significant Accounting Policies: (Cont'd)
------------------------------------------
f. Goodwill and intangible assets (cont'd)
------------------------------
The initial test for impairment required it to assess whether there
was an indication that goodwill was impaired as of the date of adoption of SFAS
No. 142. To accomplish this, the Company identified its reporting units and
determined the carrying value of each unit, including goodwill and other
intangible assets. It then determined the fair value of each reporting unit and
compared it with its carrying value. In performing this test in accordance with
SFAS No. 142, the Company aggregated the components of the reporting units to
the level where operating decisions are made. The Company completed its annual
SFAS No. 142 impairment test during the first quarter of fiscal 2003. As of June
1, 2002 it concluded that the fair values of the reporting units exceeded the
carrying values of the reporting units. Therefore, no impairment charge was
recognized in fiscal 2003 and no changes were made to the useful lives of its
intangible.

The effect of adoption of SFAS No. 142 on the 2002 and 2001
consolidated results of operations were as follows:

Years Ended May 31,
-------------------------------
2002 2001
------------- -------------
Reported loss before extraordinary item $ (2,637,832) $ (8,759,170)
Add back: amortization of goodwill 141,834 38,266
------------- -------------
Loss before extraordinary item, as adjusted $ (2,495,998) $ (8,720,904)
============= =============
Basic earnings per share:
Reported loss before extraordinary item $ (2.96) $ (14.09)
Amortization of goodwill 0.17 0.06
------------- -------------
Basic loss per share, as adjusted $ (2.79) $ (14.03)
============= =============
Diluted earnings per share:
Reported loss before extraordinary item $ (2.96) $ (14.09)
Amortization of goodwill 0.17 0.06
------------- -------------
Diluted loss per share, as adjusted $ (2.79) $ (14.03)
============= =============

g. Cash equivalents
----------------
The Company considers all highly liquid financial instruments with a
maturity of three months or less when purchased, to be cash equivalents.

h. Income taxes
------------
Deferred tax assets and liabilities are determined based on
differences between financial reporting and tax bases of assets and liabilities,
and are measured using the enacted tax rates and laws that will be in effect
when the differences are expected to reverse. Temporary differences and
carryforwards giving rise to deferred taxes primarily relate to the allowance
for doubtful accounts, depreciation, accrued expenses and net operating loss
carryforwards.

i. Stock-based compensation
------------------------
The Company applies Accounting Principles Board ("APB") Opinion No.
25 and related interpretations in accounting for stock-based compensation to
employees. Stock compensation to non-employees is accounted for at fair value in
accordance with Statement of Financial Accounting Standards ("SFAS") No. 123,
"Accounting for Stock-Based Compensation").

F-9

1. Summary of Significant Accounting Policies: (Cont'd)
------------------------------------------
i. Stock-based compensation (cont'd)
------------------------
In accordance with APB Opinion No. 25, no compensation expense has
been recognized for the stock option plans. Had the Company recorded
compensation expense for the stock options based on the fair value at the grant
date for awards in the years ended May 31, 2003, 2002 and 2001 consistent with
the provisions of SFAS No. 123, the Company's net loss and net loss per share
would have changed to the following pro forma amounts:


Years Ended May 31,
-------------------------------------------------
2003 2002 2001
------------- ------------- -------------

Net loss, as reported $ (1,328,185) $ (1,084,508) $ (9,759,170)
Net loss, pro forma (1,328,185) (1,127,508) (9,936,997)
Basic loss per share, as reported (.37) (1.36) (15.83)
Basic loss per share, pro forma (.37) (1.41) (16.12)
Diluted loss per share, as reported (.37) (1.36) (15.83)
Diluted loss per share, pro forma (.37) (1.41) (16.12)


The fair value of each option grant is estimated on the date of grant
using the Black-Scholes option pricing model with the following range of
weighted-average assumptions used for grants in years ended May 31, 2002 and
2001. There were no options granted in fiscal 2003.

Years Ended May 31,
------------------
2002 2001
------- -------
Dividend yield 0.00% 0.00%
Volatility 131.00% 128.01%
Risk-free interest rate 5.25% 5.25%
Expected life 5 years 5 years

The Black-Scholes option valuation model was developed for use in
estimating the fair value of traded options which have no vesting restrictions
and are fully transferable. In addition, option valuation models require the
input of highly subjective assumptions including the expected stock price
volatility. Because the Company's stock options have characteristics
significantly different from those of traded options, and because changes in the
subjective input assumptions can materially affect the fair value estimate, in
management's opinion, the existing models do not necessarily provide a reliable
single measure of the fair value of its stock options.

j. Use of estimates
----------------
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements. Estimates also affect the reported amounts of revenues and expenses
during the period. Such estimates primarily relate to accounts receivable
valuation allowances, recoverability of goodwill, realization of deferred tax
assets and related valuation allowances and regulatory adjustments. Actual
results may differ from those estimates.

F-10


1. Summary of Significant Accounting Policies: (Cont'd)
------------------------------------------
k. Impairment of long-lived assets
-------------------------------
In accordance with SFAS No. 144, "Accounting for the Impairment or
Disposal of Long-Lived Assets," an impairment loss is recognized whenever events
or changes in circumstances indicate that the carrying amount of an asset may
not be recoverable.

l. New accounting pronouncements
-----------------------------
In July 2001, the Financial Accounting Standards Board ("FASB")
issued SFAS No. 143, "Accounting for Asset Retirement Obligations" which
requires the recognition of a liability for an asset retirement obligation in
the period in which it is incurred. When the liability is initially recorded,
the carrying amount of the related long-lived asset is correspondingly
increased. Over time, the liability is accreted to its present value and the
related capitalized charges are depreciated over the useful life of the asset.
SFAS No. 143 is effective for fiscal years beginning after June 15, 2002.

In April 2002, SFAS No. 145, "Rescission of FASB Statements No. 4, 44
and 64, Amendment of FASB Statement No. 13, and Technical Corrections" was
issued. This statement provides guidance on the classification of gains and
losses from the extinguishment of debt and on the accounting for certain
specified lease transactions. Certain provisions of this statement related to
the classification of gains and losses from extinguishment of debt.

In June 2002, SFAS No. 146, "Accounting for Costs Associated with
Exit or Disposal Activities" was issued. This statement provides guidance on the
recognition and measurement of liabilities associated with disposal activities
and became effective for the Company on January 1, 2003.

In December 2002, the FASB issued SFAS No. 148, "Accounting for
Stock-Based Compensation - Transition and Disclosure, an Amendment of FASB
Statement No. 123," which amends SFAS No. 123, "Accounting for Stock-Based
Compensation," to provide alternative methods of transition for a voluntary
change to the fair value based method of accounting for stock-based employee
compensation. The transition and annual disclosure provisions of SFAS No. 148
are effective for fiscal years ending after December 15, 2002. In addition, SFAS
No. 148 amends the disclosure requirements of SFAS No. 123 to require prominent
disclosures in both annual and interim financial statements about the method of
accounting for stock-based employee compensation and the effect of the method
used on reported results. The Company will continue to account for stock-based
compensation to employees under APB Opinion No. 25 and related interpretations.

The adoption of SFAS Nos. 143, 145, 146 and 148 did not have a
material effect on the financial statements of the Company.

In April 2003, the FASB issued SFAS NO. 149, "Amendment of Statement
133 on Derivative Instruments and Hedging Activities." This Statement amends and
clarifies financial accounting and reporting for derivative instruments,
including certain derivative instruments embedded in other contracts
(collectively referred to as derivatives) and for hedging activities under FASB
Statement No. 133, "Accounting for Derivative Instruments and Hedging
Activities". This Statement is effective for contracts entered into or modified
after June 30, 2003 and for hedging relationships designated after June 30,
2003.

F-11

1. Summary of Significant Accounting Policies: (Cont'd)
------------------------------------------
l. New accounting pronouncements (cont'd)
-----------------------------
In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain
Financial Instruments with Characteristics of both Liabilities and Equity,"
which improves the accounting for certain financial instruments that, under
previous guidance, issuers could account for as equity. The new Statement
requires that those instruments be classified as liabilities in statements of
financial position. SFAS No. 150 also requires disclosures about alternative
ways of settling the instruments and the capital structure of entities, all of
whose shares are mandatorily redeemable. Most of the guidance in Statement 150
is effective for all financial instruments entered into or modified after May
31, 2003, and otherwise is effective at the beginning of the first interim
period beginning after June 15, 2003.

The Company is currently evaluating the impact of Statement Nos. 149
and 150. The Company does not believe that these pronouncements will have a
material effect on the financial statements.

m. Advertising costs
-----------------
Advertising costs, which are expensed as incurred, approximated $0,
$18,000 and $35,000 for the years ended May 31, 2003, 2002 and 2001,
respectively.

n. Reclassifications
-----------------
Certain reclassifications have been made to the financial statements
for the year ended May 31, 2002 to conform with the classifications used at May
31, 2003.


2. Impairment of Assets to be Disposed of:
--------------------------------------
During and subsequent to fiscal 2001, the Company initiated and
completed a plan to dispose of its New York and New Jersey offices by way of a
sale of these operations (see Note 17.) In connection with this plan of
disposal, the Company determined that the carrying value of goodwill associated
with these operations exceeded their fair values. Accordingly, a loss of
$4,205,000, which is included in operating expenses, and represents the excess
of the carrying value of approximately $8,800,000 over the fair value of
approximately $4,600,000, was charged to operations in fiscal 2001.


3. Property and Equipment:
----------------------
Property and equipment consists of the following:

May 31,
------------------------
2003 2002
---------- ----------
Furniture and fixtures $ 435,000 $ 435,000
Computer equipment 1,784,000 1,788,000
Leasehold improvements 115,000 115,000
Other 271,000 271,000
---------- ----------
2,605,000 2,609,000
Less accumulated depreciation 2,324,000 2,036,000
---------- ----------
$ 281,000 $ 573,000
========== ==========

F-12

4. Other Intangibles:
-----------------
Other intangible assets consists of the following:

May 31,
--------------------
2003 2002
-------- --------
Gross carrying amount:
Customer contracts $393,000 $395,000
Accumulated amortization 65,000 43,000
-------- --------
Balance, end of year $328,000 $352,000
======== ========

The aggregate amortization expense for each of the years ended May
31, 2003, 2002 and 2001 was approximately $21,900.

Estimated amortization expense for the five years subsequent to May
31, 2003 is as follows:

Years Ending
May 31,
-------
2004 $ 26,400
2005 26,400
2006 26,400
2007 26,400
2008 26,400

The remaining weighted-average amortization period as of May 31, 2003
is 11.75 years.

Other intangible assets are being amortized using the straight-line
method over a period of fifteen years.

5. Accrued Expenses:

Accrued expenses are as follows:

May 31,
------------------------
2003 2002
---------- ----------
Worker's compensation $ 419,000 $ 469,000
Medicaid settlement -- 270,000
Professional fees 82,000 228,000
Interest 14,000 7,000
Other 233,000 254,000
---------- ----------
$ 748,000 $1,228,000
========== ==========

6. Revolving Credit Line:
---------------------
The Company has a $2,000,000 revolving credit facility (the "Credit
Facility"). The Credit Facility permits the Company to borrow up to 85% of
eligible accounts receivable (as defined) that are aged less than 150 days at
the lender's prime rate (4.25% at May 31, 2003) plus 1%. The Credit Facility,
which expires on August 31, 2004, requires the Company to meet certain financial
ratios and covenants. All the assets of the Company collateralize the Credit
Facility.

F-13

6. Revolving Credit Line: (Cont'd)
---------------------
On December 30, 2002, the Credit Facility was amended to allow the
Company to borrow up to an additional $176,000 in excess of eligible accounts
receivable, under substantially the same terms as the basic Credit Facility.
This extension, which expires on December 31, 2003, decreases each month by
$41,667. The additional advance amount is secured by certain real estate owned
by the Company's President and CEO.

On June 12, 2003, the Credit Facility was amended again to increase
the amount of the revolving credit facility from $2,000,000 to $2,500,000, under
substantially the same terms as the original Credit Facility.


7. Due Officer:
-----------
The loans payable to the Company's President and CEO, are due on
demand and bear interest at 8% per annum.


8. Income Taxes:
------------
The Company files a consolidated U.S. federal income tax return that
includes all wholly owned subsidiaries. State tax returns are filed on a
consolidated, or separate basis depending on the applicable laws.

The provision (benefit) for income taxes from continuing operations
consists of the following:

Years Ended
May 31,
---------------------------------------
2003 2002 2001
---------- ---------- ----------
Current:
Federal $ -- $ -- $ 21,000
State and local 21,235 147,000 20,000
---------- ---------- ----------
21,235 147,000 41,000
---------- ---------- ----------
Deferred:
Federal 1,054,765 395,000 (41,000)
State and local -- -- --
---------- ---------- ----------
1,054,765 395,000 (41,000)
---------- ---------- ----------
$1,076,000 $ 542,000 $ --
========== ========== ==========

At May 31, 2003 the Company had net operating loss carryforwards for
tax purposes of approximately $9,040,000. The tax loss carryforwards expire at
various dates through 2023.

Included in the net operating loss carryforward is approximately
$8,700,000 that was subject to Internal Revenue Code Section 382, which placed a
limitation on the utilization of the federal net operating loss to approximately
$60,000 per year, as a result of a greater than 50% ownership change of Star
Multi Care Services, Inc. in fiscal 2003 (see Note 9).

F-14

8. Income Taxes: (Cont'd)
------------
The components of the net deferred tax assets are as follows:

May 31,
---------------------------
2003 2002
----------- -----------
Deferred tax assets:
Allowance for doubtful accounts $ 123,000 $ 78,000
Accrued expenses -- 117,000
Tax credits 315,000 223,000
Net operating loss carryforward 3,074,000 2,885,000
Other 43,000 12,000
----------- -----------
3,555,000 3,315,000
Valuation allowance (3,000,000) (1,337,000)
----------- -----------
555,000 1,978,000
----------- -----------
Deferred tax liabilities:
Depreciation and amortization -- 368,000
----------- -----------
-- 368,000
----------- -----------
Net deferred tax assets $ 555,000 $ 1,610,000
=========== ===========


A reconciliation between the actual income tax expense (benefit) and
income taxes computed by applying the statutory federal income tax rate to
income from continuing operations is as follows:


Years Ended
May 31,
-------------------------------------------
2003 2002 2001
----------- ----------- -----------

Computed federal income tax
at statutory rates $ (86,000) $ (713,000) $(3,318,000)
State taxes, net of federal benefit (15,000) (126,000) (586,000)
Items without tax benefit -- 1,170,000 1,709,000
Adjustments to prior years tax liability -- -- 546,000
Valuation allowance 1,000,000 -- 1,377,000
Other, net 177,000 164,000 272,000
----------- ----------- -----------
$ 1,076,000 $ 495,000 $ --
=========== =========== ===========


9. Shareholders' Equity:
--------------------
Capitalization
--------------
The Company amended its Certificate of Incorporation to increase the
authorized number of common stock shares from 5,000,000 to 20,000,000.

The Company has authorized 5,000,000 shares of preferred stock, $1.00
par value, which the Board of Directors has authority to issue from time to time
in series. The Board of Directors also has the authority to fix, before the
issuance of each series, the number of shares in each series and the
designation, preferences, rights and limitations of each series.

F-15

9. Shareholders' Equity: (Cont'd)
--------------------
Convertible Preferred Stock
---------------------------
In April 1999, the Company completed a private placement by the sale
of 575 Series A 8% Convertible Preferred Stock ("Series A Preferred") for
$575,000. After sixty days from the closing date, the Series A Preferred may be
converted to common stock equal to the lessor of: (i) 125% of the market price
of common stock three trading days immediately preceding the closing date, or
(ii) the market price of the Company's Common stock discounted from 10% to 30%,
such discount increasing with the passage of time. Holders of the Series A
Preferred can convert the stated value of their shares, in whole or in part,
into common stock at a maximum conversion price of $12.66 per share (45,432
shares), and have liquidation preference over common shareholders and Series B
Preferred. The Series A Preferred pays an 8% annual dividend payable quarterly
that may be converted to common stock at the option of the Company.

In fiscal 2003, the Company amended its certificate of incorporation
to provide for the creation of a Series B 7% Convertible Preferred Stock
("Series B Preferred"). The Board of Directors approved the authorization of 500
shares of the Series B Preferred with a par value of $1.00. The Series B
Preferred pays a 7% annual dividend payable quarterly, and may be converted to
common stock equal to the lessor of: (i) 125% of the market price of the common
stock, or (ii) the price equal to 71% of the lowest Closing Bid Price of the
common stock for the 28 day period prior to the conversion date. Holders of the
Series B Preferred have a liquidation preference over common shareholders. On
July 24, 2002, the holders of Series A Preferred exchanged all their shares,
including accrued and unpaid dividends for 477 shares of Series B Preferred.

In October 2002, Stephen Sternbach, CEO of the Company, and Matthew
Solof, former director of the Company, purchased all of the remaining issued and
outstanding Series B 7% convertible preferred stock from the Shaar Fund Ltd.

In March 2003, Sternbach and Solof converted the remaining
outstanding Series B preferred stock into 15,149,444 shares of the Company's
common stock. The conversion of the preferred shares by Sternbach and Solof
resulted in them attaining more than a majority of the outstanding common stock
in the Company.

10. Stock Option Plans:
------------------
Incentive stock option plans
----------------------------
The Company has two stock option plans (the "Plans") as adopted and
as adjusted for stock dividends. Participants may be granted either Incentive
Stock Options or Non-Qualified Stock Options to purchase shares of common stock.
The purpose of the Plans is to promote the overall financial objectives of the
Company and its shareholders by motivating those persons selected to participate
in the Plans to achieve long-term growth in shareholder equity in the Company
and by retaining the association of those individuals who are instrumental in
achieving this growth. Such options become exercisable at various intervals
based upon vesting schedules as determined by the Compensation Committee. The
options expire between September 2003 and December 2008.

The incentive stock options may be granted to employees and
consultants of the Company at a price not less than the fair market value on the
date of grant. All such options are authorized and approved by the Board of
Directors, based on recommendations of the Compensation Committee.

F-16

10. Stock Option Plans: (Cont'd)
------------------
Non-Employee Directors' Stock Option Plan
-----------------------------------------
The Company has adopted a non-qualified stock option plan for all
non-employee Directors of the Company. The plan is designed to provide an
incentive to Directors and attract and retain the services of experienced and
knowledgeable non-employee Directors. The plan expires on March 25, 2007.

A summary of the Company's various fixed stock option plans as of May
31, 2003, 2002 and 2001, and changes during the years then ended is presented
below.


Years Ended May 31,
2003 2002 2001
-------------------- --------------------- ---------------------
Weighted Weighted Weighted
Average Average Average
Exercise Exercise Exercise
Fixed Stock Options Shares Price Shares Price Shares Price
------------------- ------ ----- ------ ----- ------ -----

Outstanding, beginning of year 291,822 $ 2.63 291,459 $6.18 141,778 $11.40

Granted -- -- 130,000 0.44 167,500 1.98
Exercised -- -- -- -- (3,334) 4.13
Canceled -- -- (129,637) 8.43 (14,485) 9.11
------- ------- -------
Outstanding, end of year 291,822 $ 2.63 291,822 $ 2.63 291,459 $ 6.18
======= ======= =======
Options exercisable at year end 291,822 $ 2.63 291,822 $ 2.63 284,648 $ 6.19
======= ======= =======
Weighted average fair value of
options granted during the year $ -- $ 0.39 $ 1.64
====== ====== ======


The following table summarizes information about stock options
outstanding at May 31, 2003:


Options Outstanding Options Exercisable
-------------------------------------------- ---------------------------
Weighted
Average Weighted Weighted
Range of Remaining Average Average
Exercise Number Contractual Exercise Number Exercise
Price Outstanding Life Price Outstanding Price
----- ----------- ---- ----- ----------- -----

$.41 - $1.75 220,000 3.23 $ 1.09 220,000 $ 1.09
$3.75 - $4.13 30,939 1.23 $ 4.10 30,939 $ 4.10
$6.60 20,000 1.55 $ 6.60 20,000 $ 6.60
$11.14 - $13.61 20,327 1.36 $ 11.88 20,327 $ 11.88
$46.13 556 4.34 $ 46.13 556 $ 46.13


Shares reserved for future issuance at May 31, 2003 are comprised of
the following:

Incentive stock option plans 268,988
Non-employee Directors stock option plan 22,834
Employee stock purchase plan 35,515
-------
327,337
=======

F-17

10. Stock Option Plans: (Cont'd)
------------------
Non-Employee Directors' Stock Option Plan (cont'd)
-----------------------------------------
In November 1995, the Company adopted an Employee Stock Purchase Plan
whereby certain employees can purchase shares of common stock at the lesser of
85% of fair market value of the stock at the beginning or end of the calendar
year. Since inception of this Plan, a total of 5,088 shares were issued.


11. Related Party Transactions:
--------------------------
a. Stock subscription receivable
-----------------------------
On April 20, 1995, the Company accepted a non-recourse promissory
note from the former Chief Executive Officer of AMSERV, Eugene J. Mora, in the
original principal amount of $198,440, bearing interest at a rate of 10% per
annum and maturing in April 2001, and $1,100 in cash for the exercise of options
for 4,999 shares of the Company's common stock. The promissory note is secured
by 8,069 shares of the Company's common stock owned by Mr. Mora. On January 16,
1996, the promissory note was amended to become a recourse promissory note,
secured by 4,999 shares of common stock owned by Mr. Mora, with interest at a
rate of 5.73% per annum. Also on January 16, 1996, the Company accepted an
additional recourse promissory note from Mr. Mora in the original principal
amount of $199,342, bearing interest at a rate of 5.73% per annum and maturing
in January 2002, and $1,105 in cash for the exercise of options for 5,022 shares
of the Company's common stock.

In fiscal 2002, the Company sold certain assets related to its New
Jersey operations. The Company's New Jersey business arose primarily as a result
of the Company's acquisition of AMSERV in 1995. As a result, the Company
wrote-off the value of the non-compete in connection with the disposition of its
New Jersey business, as they deemed if not have any value subsequent to the
disposition of its New Jersey business. The write-off was included as part of
the gain on sale of business.

In accordance with the settlement agreement with Mr. Mora, the
Company agreed to forgive the subscription receivable in consideration for Mr.
Mora entering into a covenant not-to-compete agreement with the Company.
Accordingly during fiscal 2002, the Company wrote off the subscription
receivable and increased intangible assets by the amount of the note receivable
and the unpaid accrued interest in the aggregate amount of $440,000.

b. Due to shareholder
------------------
Due to shareholder, represents loans due on demand which bear
interest at 8% per annum.

12. Fair Value of Financial Instruments:
-----------------------------------

The methods and assumptions used to estimate the fair value of the
following classes of financial instruments were:

CURRENT ASSETS AND CURRENT LIABILITIES: The carrying amount of cash,
current receivables and payables and certain other short-term
financial instruments approximate their fair value.

F-18


12. Fair Value of Financial Instruments: (Cont'd)
-----------------------------------
LONG-TERM DEBT: The fair value of the Company's long-term debt,
including the current portions, was estimated using a discounted cash
flow analysis, based on the Company's assumed incremental borrowing
rates for similar types of borrowing arrangements. The carrying
amount of variable rate debt at May 31, 2003 and 2002 approximates
its fair value.

13. Concentrations of Credit Risk and Major Customers:
-------------------------------------------------
Financial instruments which potentially expose the Company to
concentrations of credit risk consist principally of trade accounts receivable
and temporary cash investments.

The Company provides temporary health care personnel to hospitals,
nursing homes, extended care facilities and in-home patients. At May 31, 2003
and 2002, approximately 65% and 40%, respectively, of accounts receivable was
due from Medicaid. Credit losses relating to customers historically have not
been significant and within management's expectations.

The Company places its temporary cash investments with high credit
quality financial institutions.

14. Business Risks:
--------------
The Company's primary business, offering home health care services,
is heavily regulated at both the federal and state levels. While the Company is
unable to predict what regulatory changes may occur or the impact of any
particular change, the Company's operations and financial results could be
negatively affected. Further, the Company operates in a highly competitive
industry, which may limit the Company's ability to price its services at levels
that they believe appropriate. These competitive factors may adversely affect
the Company's financial results.


15. Commitments:
-----------
a. Employment agreement
--------------------
The Company has an employment agreement, as amended, with an officer
which expires in December 2005. The aggregate commitment for future salary,
excluding bonuses, under the agreement is $1,264,000. The agreement also
provides for increases based on the consumer price index increases and certain
bonuses based upon annual pretax income. The aggregate minimum commitment for
future salaries under the agreement is as follows:

Years Ending
May 31,
-------
2004 $ 280,800
2005 280,800
2006 140,400
-------------
$ 702,000
=============
b. Leases
------
The Company conducts its operations from leased office space under
various operating leases which expire at various dates through 2008.

F-19

15. Commitments: (Cont'd)
-----------
b. Leases (cont'd)
------
As of May 31, 2003 future net minimum rental payments under operating
leases having initial or remaining noncancellable terms in excess of one year
are as follows:

Years Ending
May 31,
-------

2004 $ 197,000
2005 140,000
2006 67,000
2007 25,000
2008 12,000
-------------
$ 441,000
=============

Rental expenses for operating leases for fiscal years ended 2003,
2002 and 2001 were approximately $195,000, $576,000, and $621,000, respectively.


16. Contingencies:
-------------
The Company is a defendant in several actions which are routine and
incidental to its business. In management's opinion, settlement of these actions
will not have a material adverse effect on the Company's consolidated financial
position, liquidity or results of operations.


17. Gain on Sale of Business:
------------------------
On July 3, 2001 the Company entered into an agreement with Premier
Home Health Care Services, Inc. ("Premier") to sell selected assets and home
health care operations of the Company's New Jersey ("NJ Assets") and New York
("NY Assets") operations for an aggregate sales price of $5.5 million, subject
to a post closing adjustment based upon certain revenue thresholds. The
allocation of the sales price was $4.0 million for the NJ Assets, and $1.5
million for the NY Assets, respectively.

During fiscal 2002, the Company completed the sale of the NY and NJ
Assets for an adjusted sales price of $5,250,000, and recognized a gain of
approximately $313,000 on the sale, net of various transaction costs.


18. Extraordinary Item:
------------------
In February 1999, the Company adopted a plan to discontinue its
Medicare business provided by one of its subsidiaries, Star Multi Care Services
of Florida, Inc d/b/a American Health Care Services. The subsidiary ceased
operations on July 1, 1999, and in connection with its Medicare business, the
subsidiary was overpaid $2,593,324 by Medicare through its final date of
operation and was included in due Medicare on the balance sheet.

The subsidiary liquidated its assets and discharged its liabilities
through an assignment for benefit of creditors under Florida State law, and the
subsidiary was dissolved. In connection with the dissolution and liquidation of
the subsidiary, the Company has recorded an extraordinary gain of approximately
$1,553,000 (net of income taxes of $1,040,000) for the extinguishment of the
debt related to the Medicare overpayments made to the subsidiary. This gain has
been presented as an extraordinary item for the year ended May 31, 2002.

F-20

19. Discontinued Operations:
-----------------------
In February 1999, the Company adopted a plan to abandon its Medicare
business being provided by one of its subsidiaries, American Health Care
Services ("American") in the State of Florida. The Company ceased operations
effective July 1, 1999. The Company liquidated its assets and discharged its
liabilities through an assignment for the benefit of creditors proceeding.
Accordingly, the operating results of American have been segregated from
continuing operations and reported as a separate line item on the statement of
operations.

Operating results (exclusive of any corporate charges or interest
expense and the aforementioned provisions) from discontinued operations for May
31, 2001 are as follows:

Revenue, net $(1,000,000)
-----------
Costs and expenses:
Costs of revenue --
Selling, general and administrative --
Depreciation and amortization --
-----------
Operating loss (1,000,000)
Other deductions --
-----------
Loss before income taxes (1,000,000)
Income tax benefit --
-----------
Net loss $(1,000,000)
===========

20. Supplementary Information - Statement of Cash Flows:
---------------------------------------------------
During the years ended May 31, 2002 and 2001, the Company issued
72,616, and 1,829 shares of common stock in satisfaction of $22,093 and $7,545,
respectively, of dividends to preferred shareholders.


21. Selected Quarterly Financial Results (Unaudited):
------------------------------------------------

Fiscal Quarter Ended
------------------------------------------------------------
August 31, November 30, February 28, May 31,
2002 2002 2003 2003
--------- --------- --------- ----------
(In thousands except per share data)

Revenue, net $ 2,389 $ 2,562 $ 2,688 $ 2,836
Operating income (loss) (106) (4) 14 (22)
Net loss (135) (38) (1,017) (138)

Income (Loss) Per Share:
Basic (.14) (.03) (.99) (.02)
Diluted (.14) (.03) (.99) (.02)

Weighted Average Shares Outstanding:
Basic 1,011,815 1,032,865 1,032,865 12,020,374
========= ========= ========= ==========
Diluted 1,011,815 1,032,865 1,032,865 12,020,374
========= ========= ========= ==========


Income (loss) per share is computed independently for each of the
quarters presented. Therefore, the sums of the quarterly income (loss) per share
do not necessarily equal the total for the year.


F-21

ITEM 14. EXHIBITS AND REPORTS ON FORM 8-K

(a) Documents filed as part of this Report:

1. Financial Statement Schedules appear before the Index
of Exhibits.

3. Exhibits: The following Exhibits are filed as a part of
this Report:

Exhibit No. Description

3. (a) * The Company's Certificate of Incorporation
filed April 25, 1961.
(b) * The Company's Certificate of Amendment to
Certificate of Incorporation filed
February 22, 1989.
(c) The Company's Certificate of Amendment to
Certificate of Incorporation filed
December 4, 1990.
(d) The Company's Certificate of Amendment to
Certificate of Incorporation filed
February 3, 1994. (Incorporated by
reference to Exhibit 3(d) to the Company's
Annual Report on Form 10-KSB for the
fiscal year ended May 31, 1994.)
(e) Amended and Restated By-laws adopted by
the Board of Directors on February 11,
2002 file as Exhibit 3.1 to Form 10-Q for
the period ended February 28, 2002.

10. (a) * Form of Indemnification Agreement between
the Company and Stephen Sternbach.
(b) Employment Agreement, dated as of December
3, 1995 between the Company and Stephen
Sternbach. (Incorporated by reference to
Exhibit 10.(x) to the Company's Quarterly
Report on Form 10-QSB for the quarterly
period ended February 29, 1996.)
(c) * The Company's 1991 Incentive Stock Option
Plan
(d) The Company's 1992 Incentive Stock Option
Plan (as amended and restated September
13, 1993). (Incorporated by reference to
Exhibit 10 (h) to the Company's Annual
Report on Form 10-KSB for the fiscal year
ended May 31, 1994.)
(e) Amendment No. 1 to the Company's 1992
Stock Option Plan. (Incorporated by
reference to Exhibit 10. (z) to the
Company's Quarterly Report on Form 10-QSB
for the quarterly period ended February
29, 1996.)
(f) The Company's Employee Stock Purchase
Plan, as amended on December 15, 1995.
(Incorporated by reference to Exhibit 10.
(y) to the Company's Quarterly Report on
Form 10-QSB for the quarterly period ended
February 26, 1996.)


18

(g) Form of Incentive Stock Option Contract
(Incorporated by reference to Exhibit
10(j) to the Company's Annual Report on
Form 10-K for the fiscal year ended May
31, 1993.)
(h) Form of Indemnification Agreement between
the Company and directors and officers.
(Incorporated by reference to Exhibit
10(k) to the Company's Annual Report on
Form 10-K for the fiscal year ended May
31, 1992.)
(i) LOAN AND SECURITY AGREEMENT dated August
31, 2001, by and among STAR MULTI CARE
SERVICES, INC., AMSERV HEALTH CARE OF
OHIO, INC., AMSERV HEALTH CARE OF NEW
JERSEY, INC., and EFCC ACQUISITION CORP.
and HELLER HEALTHCARE FINANCE, INC.
(j) Revolving Credit Note dated August 31,
2001 for $2.0 million payable by Star
Multi Care Services, Inc., Amserv
Healthcare of Ohio, Amserv Healthcare of
New Jersey, Inc. and EFCC Acquisition
Corp. to Heller Healthcare Finance, Inc.
(k) Amendment No. 1 dated December 19, 2001 of
the LOAN AND SECURITY AGREEMENT dated
August 31, 2001, by and among STAR MULTI
CARE SERVICES, INC., AMSERV HEALTH CARE OF
OHIO, INC., AMSERV HEALTH CARE OF NEW
JERSEY, INC., and EFCC ACQUISITION CORP.
and HELLER HEALTHCARE FINANCE, INC.

21. List of subsidiaries, previously filed.

23. (a) Consent of Holtz Rubenstein & Co., LLP.
previously filed.
(b) Consent of Muenz & Meritz, P.C. included
in Exhibit 5.1. previously filed.

31.1 Certification by Stephen Sternbach
pursuant to Rule 13a-14(a) of the
Securities Exchange Act of 1934

31.2 Certification by David Schoenberg pursuant
to Rule 13a-14(a) of the Securities
Exchange Act of 1934

32.1 Certification by Stephen Sternbach
pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002

32.2 Certification by David Schoenberg pursuant
to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
___________________
* Incorporated by reference to the Company's Registration Statement on Form
S-18 dated May 14, 1991. (Registration No. 33-39697-NY)

(b) Reports on Form 8-K

The Company filed a Current Report on Form 8-K dated January 25, 2003 reporting
under Item 1. Changes in Control of the Registrant. The Company reported that
Matthew Solof, an individual investor and Stephen Sternbach, Chairman of the
Board, President and Chief Executive Officer of the Company, provided notice to
the Company that they each wished to convert all of the 234.5 shares of Series B
7% Convertible Preferred Stock (the "Preferred Stock") they hold respectively,
into common stock of the Company. Mr. Solof's and Mr. Sternbach's holdings of
Preferred Stock were each convertible into 7,574,722 shares of common stock of
the Company. The Current Report stated that upon the issuance of this common
stock pursuant to this conversion, each would hold over 45% of the outstanding
shares of the Company.
19

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act the Registrant
caused this report to be signed on its behalf by the undersigned, hereunto duly
authorized.


Date September 15, 2003 STAR MULTI CARE SERVICES, INC.


By /s/ Stephen Sternbach
------------------------
Stephen Sternbach,
Chairman of the Board, President
and Chief Executive Officer



In accordance with the Exchange Act, this Report has been signed below by
the following persons on behalf of the registrant and in the capacities and on
the dates indicated:

/s/ Stephen Sternbach Chairman of the Board, President September 15, 2003
- --------------------- and Director
Stephen Sternbach


/s/ Charles Berdan Director September 15, 2003
- ---------------------
Charles Berdan


/s/ David Schoenberg Chief Financial Officer September 15, 2003
- ---------------------
David Schoenberg



20

INDEX OF EXHIBITS

Exhibit No. Description
- ----------- -----------

3. (a) * The Company's Certificate of Incorporation filed April 25, 1961.
(b) * The Company's Certificate of Amendment to Certificate of
Incorporation filed February 22, 1989.
(c) The Company's Certificate of Amendment to Certificate of
Incorporation filed December 4, 1990.
(d) The Company's Certificate of Amendment to Certificate of
Incorporation filed February 3, 1994. (Incorporated by reference
to Exhibit 3(d) to the Company's Annual Report on Form 10-KSB
for the fiscal year ended May 31, 1994.)
(e) Amended and Restated By-laws adopted by the Board of Directors
on February 11, 2002 file as Exhibit 3.1 to Form 10-Q for the
period ended February 28, 2002.

10. (a) * Form of Indemnification Agreement between the Company and
Stephen Sternbach.
(b) Employment Agreement, dated as of December 3, 1995 between the
Company and Stephen Sternbach. (Incorporated by reference to
Exhibit 10. (x) to the Company's Quarterly Report on Form 10-QSB
for the quarterly period ended February 29, 1996.)
(c) * The Company's 1991 Incentive Stock Option Plan
(d) The Company's 1992 Incentive Stock Option Plan (as amended and
restated September 13, 1993). (Incorporated by reference to
Exhibit 10 (h) to the Company's Annual Report on Form 10-KSB for
the fiscal year ended May 31, 1994.)
(e) Amendment No. 1 to the Company's 1992 Stock Option Plan.
(Incorporated by reference to Exhibit 10. (z) to the Company's
Quarterly Report on Form 10-QSB for the quarterly period ended
February 29, 1996.)
(f) The Company's Employee Stock Purchase Plan, as amended on
December 15, 1995. (Incorporated by reference to Exhibit 10. (y)
to the Company's Quarterly Report on Form 10-QSB for the
quarterly period ended February 26, 1996.)
(g) Form of Incentive Stock Option Contract (Incorporated by
reference to Exhibit 10(j) to the Company's Annual Report on
Form 10-K for the fiscal year ended May 31, 1993.)
(h) Form of Indemnification Agreement between the Company and
directors and officers. (Incorporated by reference to Exhibit
10(k) to the Company's Annual Report on Form 10-K for the fiscal
year ended May 31, 1992.)
(i) LOAN AND SECURITY AGREEMENT dated August 31, 2001, by and among
STAR MULTI CARE SERVICES, INC., AMSERV HEALTH CARE OF OHIO,
INC., AMSERV HEALTH CARE OF NEW JERSEY, INC., and EFCC
ACQUISITION CORP. and HELLER HEALTHCARE FINANCE, INC.
(j) Revolving Credit Note dated August 31, 2001 for $2.0 million
payable by Star Multi Care Services, Inc., Amserv Healthcare of
Ohio, Amserv Healthcare of New Jersey, Inc. and EFCC Acquisition
Corp. to Heller Healthcare Finance, Inc.
(k) Amendment No. 1 dated December 19, 2001 of the LOAN AND SECURITY
AGREEMENT dated August 31, 2001, by and among STAR MULTI CARE
SERVICES, INC., AMSERV HEALTH CARE OF OHIO, INC., AMSERV HEALTH
CARE OF NEW JERSEY, INC., and EFCC ACQUISITION CORP. and HELLER
HEALTHCARE FINANCE, INC.

21. List of subsidiaries, previously filed.

23. (a) Consent of Holtz Rubenstein & Co., LLP. previously filed.
(b) Consent of Muenz & Meritz, P.C. included in Exhibit 5.1.
previously filed.

31.1 Certification by Stephen Sternbach pursuant to Rule 13a-14(a) of
the Securities Exchange Act of 1934

31.2 Certification by David Schoenberg pursuant to Rule 13a-14(a) of
the Securities Exchange Act of 1934

32.1 Certification by Stephen Sternbach pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002

32.2 Certification by David Schoenberg pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002

___________________

* Incorporated by reference to the Company's Registration Statement on Form
S-18 dated May 14, 1991. (Registration No. 33-39697-NY)

21